BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676. [PMID: 12778165 DOI: 10.1038/nm0603-669] [Cited by in Crossref: 6194] [Cited by in F6Publishing: 5722] [Article Influence: 326.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao J, Feng Y. Surface Engineering of Cardiovascular Devices for Improved Hemocompatibility and Rapid Endothelialization. Adv Healthcare Mater 2020;9:2000920. [DOI: 10.1002/adhm.202000920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Lai L, Pen A, Hu Y, Ma J, Chen J, Hao C, Gu Y, Lin S. Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor. Life Sciences 2007;81:570-6. [DOI: 10.1016/j.lfs.2007.06.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
3 Pang YH, Lei CZ, Zhang CL, Lan XY, Shao SM, Gao XM, Chen H. Single Nucleotide Polymorphisms of the Bovine VEGF-B Gene and Their Associations with Growth Traits in the Nanyang Cattle Breed. Animal Biotechnology 2012;23:225-32. [DOI: 10.1080/10495398.2012.700290] [Reference Citation Analysis]
4 Lorusso D, Ferrandina G, Fanfani F, Gagliardi ML, Scambia G. Investigational agents against platinum-resistant ovarian cancer. Expert Opinion on Investigational Drugs 2007;16:325-36. [DOI: 10.1517/13543784.16.3.325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Li M, Jia Q, Chen T, Zhao Z, Chen J, Zhang J. The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury. Clin Neurol Neurosurg 2016;144:7-13. [PMID: 26945876 DOI: 10.1016/j.clineuro.2016.02.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
6 Jantus-Lewintre E, Massutí Sureda B, González Larriba JL, Rodríguez-Abreu D, Juan O, Blasco A, Dómine M, Provencio Pulla M, Garde J, Álvarez R, Maestu I, Pérez de Carrión R, Artal Á, Rolfo C, de Castro J, Guillot M, Oramas J, de Las Peñas R, Ferrera L, Martínez N, Serra Ò, Rosell R, Camps C. Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study. Front Oncol 2021;11:695038. [PMID: 34381717 DOI: 10.3389/fonc.2021.695038] [Reference Citation Analysis]
7 Benayoun Y, Petellat F, Leclerc O, Dost L, Dallaudière B, Reddy C, Robert PY, Salomon JL. [Current treatments for corneal neovascularization]. J Fr Ophtalmol 2015;38:996-1008. [PMID: 26522890 DOI: 10.1016/j.jfo.2015.09.006] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Guerra A, Belinha J, Natal Jorge R. A preliminary study of endothelial cell migration during angiogenesis using a meshless method approach. Int J Numer Meth Biomed Engng 2020;36. [DOI: 10.1002/cnm.3393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Muniz JJ, Izidoro-toledo TC, Metzger IF, Sandrim VC, Tanus-santos JE. Interethnic Differences in the Distribution of Clinically Relevant Vascular Endothelial Growth Factor Genetic Polymorphisms. DNA and Cell Biology 2009;28:567-72. [DOI: 10.1089/dna.2009.0925] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
10 Fischerauer E, Heidari N, Neumayer B, Deutsch A, Weinberg AM. The spatial and temporal expression of VEGF and its receptors 1 and 2 in post-traumatic bone bridge formation of the growth plate. J Mol Hist 2011;42:513-22. [DOI: 10.1007/s10735-011-9359-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Diana D, Russomanno A, De Rosa L, Di Stasi R, Capasso D, Di Gaetano S, Romanelli A, Russo L, D'Andrea LD, Fattorusso R. Functional binding surface of a β-hairpin VEGF receptor targeting peptide determined by NMR spectroscopy in living cells. Chemistry 2015;21:91-5. [PMID: 25378243 DOI: 10.1002/chem.201403335] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
12 Sampath D, Oeh J, Wyatt SK, Cao TC, Koeppen H, Eastham-Anderson J, Robillard L, Ho CC, Ross J, Zhuang G, Reslan HB, Vitorino P, Barck KH, Ungersma SE, Vernes JM, Caunt M, Van Bruggen N, Ye W, Vijapurkar U, Meng YJ, Ferrara N, Friedman LS, Carano RA. Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response. Neoplasia 2013;15:694-711. [PMID: 23814482 DOI: 10.1593/neo.13470] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
13 Elia R, Fuegy PW, VanDelden A, Firpo MA, Prestwich GD, Peattie RA. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials 2010;31:4630-8. [PMID: 20227760 DOI: 10.1016/j.biomaterials.2010.02.043] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
14 Grimminger CM, Danenberg PV. Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. Eur Arch Otorhinolaryngol 2011;268:5-16. [PMID: 20827554 DOI: 10.1007/s00405-010-1369-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
15 Li J, Gao X, Tian S, Tang M, Liu W. Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma. Future Oncol 2021;17:4745-56. [PMID: 34658257 DOI: 10.2217/fon-2021-0261] [Reference Citation Analysis]
16 Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 2004;10:143-5. [PMID: 15162796 DOI: 10.1016/j.molmed.2004.02.001] [Cited by in Crossref: 165] [Cited by in F6Publishing: 154] [Article Influence: 9.2] [Reference Citation Analysis]
17 Zygalaki E, Kaklamanis L, Nikolaou NI, Kyrzopoulos S, Houri M, Kyriakides Z, Lianidou ES, Kremastinos DT. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease. Clin Biochem 2008;41:82-7. [PMID: 17961532 DOI: 10.1016/j.clinbiochem.2007.09.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tan G, Onur MA. Anti-proliferative effects of gold nanoparticles functionalized with Semaphorin 3F. J Nanopart Res 2017;19. [DOI: 10.1007/s11051-017-3967-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang Y, Zhang F, Wang J, Hu L, Jiang F, Chen J, Chen J, Wang L. lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma. Cancer Manag Res 2018;10:4257-66. [PMID: 30323681 DOI: 10.2147/CMAR.S177327] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
20 Han B, Baliga R, Huang H, Giannone PJ, Bauer JA. Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2009;297:H829-35. [PMID: 19561313 DOI: 10.1152/ajpheart.00222.2009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
21 Bridgett S, Dellett M, Simpson DA. RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAxxxb isoforms. Sci Rep 2017;7:58. [PMID: 28246395 DOI: 10.1038/s41598-017-00100-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
22 Patra CR, Kim JH, Pramanik K, d'Uscio LV, Patra S, Pal K, Ramchandran R, Strano MS, Mukhopadhyay D. Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano Lett 2011;11:4932-8. [PMID: 21967244 DOI: 10.1021/nl2028766] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
23 Song C, Ma H, Yao C, Tao X, Gan H. Alveolar macrophage-derived vascular endothelial growth factor contributes to allergic airway inflammation in a mouse asthma model. Scand J Immunol 2012;75:599-605. [PMID: 22324377 DOI: 10.1111/j.1365-3083.2012.02693.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
24 Rutto KV, Lyamina IV, Kudryavtsev IV, Kiseleva EP. Regulation of vascular endothelial growth factor production in mouse thymic epithelial cell lines. Cell Tiss Biol 2016;10:387-94. [DOI: 10.1134/s1990519x16050126] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH; American Society of Nephrology Onco-Nephrology Forum. The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma. J Am Soc Nephrol 2016;27:2227-37. [PMID: 26961346 DOI: 10.1681/ASN.2015121335] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
26 Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 2006;580:2879-2887. [PMID: 16631753 DOI: 10.1016/j.febslet.2006.03.087] [Cited by in Crossref: 317] [Cited by in F6Publishing: 305] [Article Influence: 19.8] [Reference Citation Analysis]
27 Zorena K, Myśliwska J, Myśliwiec M, Rybarczyk-Kapturska K, Malinowska E, Wiśniewski P, Raczyńska K. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. J Hum Hypertens 2010;24:755-62. [PMID: 20164848 DOI: 10.1038/jhh.2010.7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
28 Canavese M, Altruda F, Ruzicka T, Schauber J. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies? J Dermatol Sci 2010;58:171-6. [PMID: 20430590 DOI: 10.1016/j.jdermsci.2010.03.023] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
29 Pereza N, Ostojić S, Smirčić A, Hodžić A, Kapović M, Peterlin B. The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion. J Assist Reprod Genet 2015;32:1789-94. [PMID: 26475697 DOI: 10.1007/s10815-015-0593-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
30 Qin S, Yi M, Jiao D, Li A, Wu K. Distinct Roles of VEGFA and ANGPT2 in Lung Adenocarcinoma and Squamous Cell Carcinoma. J Cancer 2020;11:153-67. [PMID: 31892982 DOI: 10.7150/jca.34693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
31 Hsu CL, Lien CW, Wang CW, Harroun SG, Huang CC, Chang HT. Immobilization of aptamer-modified gold nanoparticles on BiOCl nanosheets: Tunable peroxidase-like activity by protein recognition. Biosens Bioelectron 2016;75:181-7. [PMID: 26318787 DOI: 10.1016/j.bios.2015.08.049] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
32 Jazwa A, Stoszko M, Tomczyk M, Bukowska-strakova K, Pichon C, Jozkowicz A, Dulak J. HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses — Effects modified by concomitant VEGF overexpression. Vascular Pharmacology 2015;71:127-38. [DOI: 10.1016/j.vph.2015.02.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
33 Tong Q, Zhao Q, Qing Y, Hu X, Jiang L, Wu X. Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells. Steroids 2015;96:30-6. [DOI: 10.1016/j.steroids.2014.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Araújo RS, Bitoque DB, Silva GA. Dual-Acting Antiangiogenic Gene Therapy Reduces Inflammation and Regresses Neovascularization in Diabetic Mouse Retina. Mol Ther Nucleic Acids 2020;22:329-39. [PMID: 33230438 DOI: 10.1016/j.omtn.2020.08.036] [Reference Citation Analysis]
35 Pihan M, Keddie S, D'Sa S, Church AJ, Yong KL, Reilly MM, Lunn MP. Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome. Neurol Neuroimmunol Neuroinflamm 2018;5:e486. [PMID: 30175160 DOI: 10.1212/NXI.0000000000000486] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
36 Murphy A, Kelly RJ. From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer. Gastroenterol Res Pract 2015;2015:896560. [PMID: 25784931 DOI: 10.1155/2015/896560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Mizuno Y, Taguchi T. Self-assembled dodecyl group-modified gelatin microparticle-based hydrogels with angiogenic properties. NPG Asia Mater 2020;12. [DOI: 10.1038/s41427-020-0229-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Yi K, Jung S, Cho G, Seol H, Hong S, Oh M, Kim H. Effects of sFlt-1 and alpha 2-macroglobulin on vascular endothelial growth factor-induced endothelin-1 upregulation in human microvascular endothelial cells. Placenta 2014;35:64-9. [DOI: 10.1016/j.placenta.2013.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Takahashi H, Ojima H, Shimizu H, Furuse J, Furukawa H, Shibata T. Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma. Jpn J Clin Oncol. 2014;44:570-578. [PMID: 24755544 DOI: 10.1093/jjco/hyu045] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
40 Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28:1-18. [PMID: 19026761 DOI: 10.1016/j.preteyeres.2008.10.001] [Cited by in Crossref: 318] [Cited by in F6Publishing: 332] [Article Influence: 22.7] [Reference Citation Analysis]
41 Borghesi J, Caceres S, Mario LC, Alonso-Diez A, Silveira Rabelo AC, Illera MJ, Silvan G, Miglino MA, Favaron PO, Carreira ACO, Illera JC. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells. BMC Vet Res 2020;16:353. [PMID: 32972410 DOI: 10.1186/s12917-020-02576-0] [Reference Citation Analysis]
42 Dei Cas A, Gnudi L. VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? Metabolism 2012;61:1666-73. [PMID: 22554833 DOI: 10.1016/j.metabol.2012.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
43 Yang J, Zhang W, Shi P, Chen J, Han X, Wang Y. Effects of exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis fungus on c-Myc, c-Fos, and VEGF expression in B16 melanoma-bearing mice. Pathology - Research and Practice 2005;201:745-50. [DOI: 10.1016/j.prp.2005.08.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
44 Zhang Y, Yao Z, Kaila N, Kuebler P, Visich J, Maia M, Tuomi L, Ehrlich JS, Rubio RG, Campochiaro PA. Pharmacokinetics of Ranibizumab after Intravitreal Administration in Patients with Retinal Vein Occlusion or Diabetic Macular Edema. Ophthalmology 2014;121:2237-46. [DOI: 10.1016/j.ophtha.2014.05.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
45 Li M, Wu S, Liu Z, Zhang W, Xu J, Wang Y, Liu J, Zhang D, Tian H, Li Y, Ye W. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway. Biochem Pharmacol 2012;83:1251-60. [PMID: 22305746 DOI: 10.1016/j.bcp.2012.01.023] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
46 De Rosa L, Diana D, Basile A, Russomanno A, Isernia C, Turco MC, Fattorusso R, D'andrea LD. Design, structural and biological characterization of a VEGF inhibitor β-hairpin-constrained peptide. European Journal of Medicinal Chemistry 2014;73:210-6. [DOI: 10.1016/j.ejmech.2013.12.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
47 Mancuso MR, Kuhnert F, Kuo CJ. Developmental angiogenesis of the central nervous system. Lymphat Res Biol 2008;6:173-80. [PMID: 19093790 DOI: 10.1089/lrb.2008.1014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
48 Liu B, Ma Z, Li J, Xie H, Wei X, Wang B, Tian S, Yang J, Yang L, Cheng L, Li L, Zhao D. Experimental study of a 3D printed permanent implantable porous Ta-coated bone plate for fracture fixation. Bioact Mater 2022;10:269-80. [PMID: 34901545 DOI: 10.1016/j.bioactmat.2021.09.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Seedorf G, Metoxen AJ, Rock R, Markham N, Ryan S, Vu T, Abman SH. Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung. Am J Physiol Lung Cell Mol Physiol 2016;310:L1098-110. [PMID: 27036872 DOI: 10.1152/ajplung.00423.2015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
50 Yasumitsu A, Tabata C, Tabata R, Hirayama N, Murakami A, Yamada S, Terada T, Iida S, Tamura K, Fukuoka K, Kuribayashi K, Nakano T. Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology 2010;5:479-83. [DOI: 10.1097/jto.0b013e3181d2f008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
51 Tong Q, Zheng L, Li B, Wang D, Huang C, Matuschak GM, Li D. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. Exp Cell Res 2006;312:3559-69. [PMID: 16982054 DOI: 10.1016/j.yexcr.2006.07.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
52 Cevik O, Li D, Baljinnyam E, Manvar D, Pimenta EM, Waris G, Barnes BJ, Kaushik-Basu N. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma. J Biol Chem 2017;292:21676-89. [PMID: 29079574 DOI: 10.1074/jbc.M117.792721] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
53 Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR, Im HJ. Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res 2016;31:911-24. [PMID: 27163679 DOI: 10.1002/jbmr.2828] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 14.2] [Reference Citation Analysis]
54 Zhang H, He Y, Dai S, Xu Z, Luo Y, Wan T, Luo D, Jones D, Tang S, Chen H, Sessa WC, Min W. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J Clin Invest 2008;118:3904-16. [PMID: 19033661 DOI: 10.1172/JCI36168] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
55 Meng L, Gan S, Zhou Y, Cheng Y, Ding Y, Tong X, Wu J, Hu Y, Yuan A. Oxygen-rich chemotherapy via modified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer. Biomater Sci 2019;7:168-77. [DOI: 10.1039/c8bm00753e] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
56 Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina. 2009;29:875-912. [PMID: 19584648 DOI: 10.1097/iae.0b013e3181a94f01] [Cited by in Crossref: 134] [Cited by in F6Publishing: 51] [Article Influence: 10.3] [Reference Citation Analysis]
57 Cruz SM, Girão AF, Gonçalves G, Marques PA. Graphene: The Missing Piece for Cancer Diagnosis? Sensors (Basel) 2016;16:E137. [PMID: 26805845 DOI: 10.3390/s16010137] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
58 Zong J, Keskinov AA, Shurin GV, Shurin MR. Tumor-derived factors modulating dendritic cell function. Cancer Immunol Immunother 2016;65:821-33. [PMID: 26984847 DOI: 10.1007/s00262-016-1820-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
59 Pauli FP, Martins JR, Paschoalin T, Ionta M, Barbosa MLC, Barreiro EJ. Novel VEGFR‐2 inhibitors with an N ‐acylhydrazone scaffold. Arch Pharm 2020;353:2000130. [DOI: 10.1002/ardp.202000130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Adjei AA. Targeting multiple signal transduction pathways in lung cancer. Clin Lung Cancer 2005;7 Suppl 1:S39-44. [PMID: 16159418 DOI: 10.3816/clc.2005.s.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
61 Langer CJ, Natale RB. The Emerging Role of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors. Seminars in Oncology 2005;32:23-9. [DOI: 10.1053/j.seminoncol.2005.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
62 D'andrea LD, Gatto A, Pedone C, Benedetti E. Peptide-based Molecules in Angiogenesis. Chem Biol Drug Design 2006;67:115-26. [DOI: 10.1111/j.1747-0285.2006.00356.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
63 Yang W, Jiang Y, Wang Y, Zhang T, Liu Q, Wang C, Swisher G, Wu N, Chao C, Prasadan K, Gittes GK, Xiao X. Placental growth factor in beta cells plays an essential role in gestational beta-cell growth. BMJ Open Diabetes Res Care 2020;8:e000921. [PMID: 32144129 DOI: 10.1136/bmjdrc-2019-000921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
64 Ghanaati S, Webber MJ, Unger RE, Orth C, Hulvat JF, Kiehna SE, Barbeck M, Rasic A, Stupp SI, Kirkpatrick CJ. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials 2009;30:6202-12. [PMID: 19683342 DOI: 10.1016/j.biomaterials.2009.07.063] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
65 Kühn C, Checa S. Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis. Front Physiol 2019;10:288. [PMID: 30971939 DOI: 10.3389/fphys.2019.00288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
66 Henidi B, Kaabachi W, Naouali A, Kaabachi S, Zhioua A, Haj Sassi F, Hamzaoui K. Vascular endothelial growth factor (-460 C/T, +405 G/C, and +936 C/T) polymorphisms and endometriosis risk in Tunisian population. Syst Biol Reprod Med 2015;61:238-44. [PMID: 25984730 DOI: 10.3109/19396368.2015.1041622] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
67 Lee H, Chung HJ, Park TG. Perspectives On: Local and Sustained Delivery of Angiogenic Growth Factors. Journal of Bioactive and Compatible Polymers 2007;22:89-114. [DOI: 10.1177/0883911506073363] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
68 Huo M, Wang L, Chen Y, Shi J. Oxygen Pathology and Oxygen-Functional Materials for Therapeutics. Matter 2020;2:1115-47. [DOI: 10.1016/j.matt.2020.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
69 Kimura Y, Sumiyoshi M, Taniguchi M, Baba K. Antitumor and antimetastatic actions of anthrone-C-glucoside, cassialoin isolated from Cassia garrettiana heartwood in colon 26-bearing mice. Cancer Science 2008;99:2336-48. [DOI: 10.1111/j.1349-7006.2008.00938.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
70 Münch V, Trentin L, Herzig J, Demir S, Seyfried F, Kraus JM, Kestler HA, Köhler R, Barth TFE, Te Kronnie G, Debatin KM, Meyer LH. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. Blood 2017;130:643-54. [PMID: 28550041 DOI: 10.1182/blood-2017-03-769315] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
71 Wang L, Gagey-Eilstein N, Broussy S, Reille-Seroussi M, Huguenot F, Vidal M, Liu WQ. Design and synthesis of C-terminal modified cyclic peptides as VEGFR1 antagonists. Molecules 2014;19:15391-407. [PMID: 25264829 DOI: 10.3390/molecules191015391] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
72 Campos A, Campos EJ, Martins J, Rodrigues FSC, Silva R, Ambrósio AF. Inflammatory cells proliferate in the choroid and retina without choroidal thickness change in early Type 1 diabetes. Exp Eye Res 2020;199:108195. [PMID: 32841650 DOI: 10.1016/j.exer.2020.108195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Meier R, Braren R, Kosanke Y, Bussemer J, Neff F, Wildgruber M, Schwarzenböck S, Frank A, Haller B, Hohlbaum AM, Schwaiger M, Gille H, Rummeny EJ, Beer AJ. Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins. PLoS One 2014;9:e94972. [PMID: 24801709 DOI: 10.1371/journal.pone.0094972] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
74 Nensa F, Stattaus J, Morgan B, Horsfield MA, Soria J, Besse B, Gounant V, Khalil A, Seng K, Fischer B, Krissel H, Laurent D, Christoph D, Eberhardt WE, Gauler TC. Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer. Future Oncology 2014;10:823-33. [DOI: 10.2217/fon.13.248] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
75 Khojasteh A, Fahimipour F, Jafarian M, Sharifi D, Jahangir S, Khayyatan F, Baghaban Eslaminejad M. Bone engineering in dog mandible: Coculturing mesenchymal stem cells with endothelial progenitor cells in a composite scaffold containing vascular endothelial growth factor. J Biomed Mater Res B Appl Biomater 2017;105:1767-77. [PMID: 27186846 DOI: 10.1002/jbm.b.33707] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
76 Wu Z, Shao P, Dass CR, Wei Y. Systemic leptin administration alters callus VEGF levels and enhances bone fracture healing in wildtype and ob/ob mice. Injury 2018;49:1739-45. [PMID: 30244701 DOI: 10.1016/j.injury.2018.06.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
77 Li L, Pan Y, Dai L, Liu B, Zhang D. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease. Med Sci Monit 2016;22:31-40. [PMID: 26726843 DOI: 10.12659/msm.895163] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
78 Selvaraj S, Raundhal M, Patidar A, Saha B. Anti-VEGF antibody enhances the antitumor effect of CD40. Int J Cancer 2014;135:1983-8. [PMID: 24604357 DOI: 10.1002/ijc.28833] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
79 Mou P, Peng H, Zhou L, Li L, Li H, Huang Q. A novel composite scaffold of Cu-doped nano calcium-deficient hydroxyapatite/multi-(amino acid) copolymer for bone tissue regeneration. Int J Nanomedicine 2019;14:3331-43. [PMID: 31123401 DOI: 10.2147/IJN.S195316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
80 Vincenzi B, Santini D, Russo A, Spoto C, Venditti O, Gasparro S, Rizzo S, Zobel BB, Caricato M, Valeri S. Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial. Cancer. 2009;115:4849-4856. [PMID: 19626652 DOI: 10.1002/cncr.24540] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
81 Sini V, Cassano A, Corsi D, De Laurentiis M, Gamucci T, Mauri M, Naso G, Roselli M, Ruggeri EM, Tonini G, Vici P, Zampa G, Marchetti P. Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons. Tumori 2016;102:472-80. [PMID: 27647231 DOI: 10.5301/tj.5000555] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
82 Pronto-Laborinho AC, Pinto S, de Carvalho M. Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis. Biomed Res Int 2014;2014:947513. [PMID: 24987705 DOI: 10.1155/2014/947513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
83 Lai KC, Hsu SC, Yang JS, Yu CC, Lein JC, Chung JG. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth. J Cell Mol Med 2015;19:474-84. [PMID: 25403643 DOI: 10.1111/jcmm.12486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
84 Bengoetxea H, Rico-Barrio I, Ortuzar N, Murueta-Goyena A, Lafuente JV. Environmental Enrichment Reverses Tyrosine Kinase Inhibitor-Mediated Impairment Through BDNF-TrkB Pathway. Mol Neurobiol 2018;55:43-59. [PMID: 28842826 DOI: 10.1007/s12035-017-0716-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
85 Phetfong J, Supokawej A, Wattanapanitch M, Kheolamai P, U-Pratya Y, Issaragrisil S. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage. Cell Tissue Res 2016;365:101-12. [PMID: 26893154 DOI: 10.1007/s00441-016-2369-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
86 Yang Q, Ni L, Imani S, Xiang Z, Hai R, Ding R, Fu S, Wu JB, Wen Q. Anlotinib Suppresses Colorectal Cancer Proliferation and Angiogenesis via Inhibition of AKT/ERK Signaling Cascade. Cancer Manag Res 2020;12:4937-48. [PMID: 32606981 DOI: 10.2147/CMAR.S252181] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
87 Bach MH, Sadoun E, Reed MJ. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging. Mech Ageing Dev 2005;126:467-73. [PMID: 15722105 DOI: 10.1016/j.mad.2004.10.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
88 Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA. Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells. Carcinogenesis 2019;40:2-14. [PMID: 30475990 DOI: 10.1093/carcin/bgy171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
89 Impellitteri NA, Toepke MW, Lan Levengood SK, Murphy WL. Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres. Biomaterials 2012;33:3475-84. [PMID: 22322198 DOI: 10.1016/j.biomaterials.2012.01.032] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
90 Lin K, Xia L, Li H, Jiang X, Pan H, Xu Y, Lu WW, Zhang Z, Chang J. Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. Biomaterials 2013;34:10028-42. [PMID: 24095251 DOI: 10.1016/j.biomaterials.2013.09.056] [Cited by in Crossref: 217] [Cited by in F6Publishing: 198] [Article Influence: 24.1] [Reference Citation Analysis]
91 Choedon T, Dolma D, Mathan G, Kumar V. Molecular insights into the anti-cancer properties of traditional Tibetan medicine Yukyung Karne. BMC Complement Altern Med 2014;14:380. [PMID: 25292320 DOI: 10.1186/1472-6882-14-380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
92 Vieira de Castro J, Gomes ED, Granja S, Anjo SI, Baltazar F, Manadas B, Salgado AJ, Costa BM. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology. J Transl Med 2017;15:200. [PMID: 28969635 DOI: 10.1186/s12967-017-1303-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
93 Schmidt NO, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, Black PM, Aboody KS, Carroll RS. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005;7:623-9. [PMID: 16036113 DOI: 10.1593/neo.04781] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 9.0] [Reference Citation Analysis]
94 Madu CO, Wang S, Madu CO, Lu Y. Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment. J Cancer 2020;11:4474-94. [PMID: 32489466 DOI: 10.7150/jca.44313] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
95 Holderfield MT, Henderson Anderson AM, Kokubo H, Chin MT, Johnson RL, Hughes CC. HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes. Biochemical and Biophysical Research Communications 2006;346:637-48. [DOI: 10.1016/j.bbrc.2006.05.177] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
96 Breen EC. VEGF in biological control. J Cell Biochem. 2007;102:1358-1367. [PMID: 17979153 DOI: 10.1002/jcb.21579] [Cited by in Crossref: 136] [Cited by in F6Publishing: 124] [Article Influence: 9.7] [Reference Citation Analysis]
97 Konopleva M, Tabe Y, Zeng Z, Andreeff M. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. Drug Resist Updat 2009;12:103-13. [PMID: 19632887 DOI: 10.1016/j.drup.2009.06.001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 8.7] [Reference Citation Analysis]
98 Zhu AX, Finn RS, Mulcahy M, Gurtler J, Sun W, Schwartz JD, Dalal RP, Joshi A, Hozak RR, Xu Y, Ancukiewicz M, Jain RK, Nugent FW, Duda DG, Stuart K. A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer. Clin Cancer Res. 2013;19:6614-6623. [PMID: 24088738 DOI: 10.1158/1078-0432.ccr-13-1442] [Cited by in Crossref: 99] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
99 Hanga MP, Nienow AW, Murasiewicz H, Pacek AW, Hewitt CJ, Coopman K. Expansion of human mesenchymal stem/stromal cells on temporary liquid microcarriers. J Chem Technol Biotechnol 2021;96:930-40. [PMID: 33776183 DOI: 10.1002/jctb.6601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis. 2017;20:185-204. [PMID: 28361267 DOI: 10.1007/s10456-017-9552-y] [Cited by in Crossref: 215] [Cited by in F6Publishing: 220] [Article Influence: 43.0] [Reference Citation Analysis]
101 Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, Ruffini F, Pesce M, Cianfarani F, Zambruno G, Orlandi A, Failla CM. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 2006;169:643-54. [PMID: 16877362 DOI: 10.2353/ajpath.2006.051041] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
102 Cignarella A, Fadini GP, Bolego C, Trevisi L, Boscaro C, Sanga V, Seccia TM, Rosato A, Rossi GP, Barton M. Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges. Cardiovasc Res 2021:cvab096. [PMID: 33739385 DOI: 10.1093/cvr/cvab096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Fan Y, Arif A, Gong Y, Jia J, Eswarappa SM, Willard B, Horowitz A, Graham LM, Penn MS, Fox PL. Stimulus-dependent phosphorylation of profilin-1 in angiogenesis. Nat Cell Biol 2012;14:1046-56. [PMID: 23000962 DOI: 10.1038/ncb2580] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
104 Jiang R, Dong C, Chen Z, Cheng S, Yang J, Gao W, Lloret A. Catalpol Enhances Random-Pattern Skin Flap Survival by Activating SIRT1-Mediated Enhancement of Autophagy. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/5668226] [Reference Citation Analysis]
105 Saygili E, Noor-Ebad F, Schröder JW, Mischke K, Saygili E, Rackauskas G, Marx N, Kelm M, Rana OR. Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes. Biochem Biophys Res Commun 2015;465:119-24. [PMID: 26248134 DOI: 10.1016/j.bbrc.2015.07.143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
106 Liu L, Suzuki H. The Role of Matricellular Proteins in Experimental Subarachnoid Hemorrhage-Induced Early Brain Injury. In: Lapchak PA, Zhang JH, editors. Cellular and Molecular Approaches to Regeneration and Repair. Cham: Springer International Publishing; 2018. pp. 397-407. [DOI: 10.1007/978-3-319-66679-2_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
107 Benderro GF, Tsipis CP, Sun X, Kuang Y, Lamanna JC. Increased HIF-1α and HIF-2α Accumulation, but Decreased Microvascular Density, in Chronic Hyperoxia and Hypercapnia in the Mouse Cerebral Cortex. In: Van Huffel S, Naulaers G, Caicedo A, Bruley DF, Harrison DK, editors. Oxygen Transport to Tissue XXXV. New York: Springer; 2013. pp. 29-35. [DOI: 10.1007/978-1-4614-7411-1_5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
108 Lv J, Liu J, Guo L, Zhang J, Cheng Y, Chen C, Zhao H, Wang J. Bioinformatic analyses of microRNA-targeted genes and microarray-identified genes correlated with Barrett's esophagus. Cell Cycle 2018;17:792-800. [PMID: 29417867 DOI: 10.1080/15384101.2018.1431597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
109 Géczi L, Bodoky G, Rokszin G, Fábián I, Torday L. Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Pathol Oncol Res 2020;26:2201-7. [PMID: 32291570 DOI: 10.1007/s12253-020-00809-z] [Reference Citation Analysis]
110 Moriarity A, O'Sullivan J, Kennedy J, Mehigan B, McCormick P. Current targeted therapies in the treatment of advanced colorectal cancer: a review. Ther Adv Med Oncol. 2016;8:276-293. [PMID: 27482287 DOI: 10.1177/1758834016646734] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
111 Bryan BA, Dennstedt E, Mitchell DC, Walshe TE, Noma K, Loureiro R, Saint-Geniez M, Campaigniac JP, Liao JK, D’Amore PA. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J. 2010;24:3186-3195. [PMID: 20400538 DOI: 10.1096/fj.09-145102] [Cited by in Crossref: 166] [Cited by in F6Publishing: 162] [Article Influence: 13.8] [Reference Citation Analysis]
112 Kurosaka M, Suzuki T, Hosono K, Kamata Y, Fukamizu A, Kitasato H, Fujita Y, Majima M. Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. Biomedicine & Pharmacotherapy 2009;63:627-34. [DOI: 10.1016/j.biopha.2009.01.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
113 Bradshaw M, Mansfield A, Peikert T. The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion. Curr Oncol Rep 2013;15:207-16. [PMID: 23568600 DOI: 10.1007/s11912-013-0315-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
114 Gille J. Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches. Exp Dermatol. 2006;15:175-186. [PMID: 16480425 DOI: 10.1111/j.1600-0625.2006.00400.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
115 Li X, Huang C, Sui CL, Liang CM, Qi GY, Ren QY, Chen J, Huang ZQ. Formononetin, J1 and J2 have different effects on endothelial cells via EWSAT1-TRAF6 and its downstream pathway. J Cell Mol Med 2020;24:875-85. [PMID: 31742893 DOI: 10.1111/jcmm.14797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
116 Milesi-Hallé A, McCullough S, Hinson JA, Kurten RC, Lamps LW, Brown A, James LP. Echinomycin decreases induction of vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity in mice. Basic Clin Pharmacol Toxicol 2012;110:327-34. [PMID: 21985601 DOI: 10.1111/j.1742-7843.2011.00812.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
117 Bai ZG, Zhang ZT. A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer. Onco Targets Ther 2018;11:7077-87. [PMID: 30410364 DOI: 10.2147/OTT.S169484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
118 Wang J, Li W, Lu Z, Zhang L, Hu Y, Li Q, Du W, Feng X, Jia H, Liu BF. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis. Nanoscale 2017;9:15598-605. [PMID: 28990632 DOI: 10.1039/c7nr04425a] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
119 Krueger J, Liu D, Scholz K, Zimmer A, Shi Y, Klein C, Siekmann A, Schulte-Merker S, Cudmore M, Ahmed A, le Noble F. Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo. Development 2011;138:2111-20. [PMID: 21521739 DOI: 10.1242/dev.063933] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 10.0] [Reference Citation Analysis]
120 Akhavani MA, Sivakumar B, Paleolog EM, Kang N. Angiogenesis and plastic surgery. J Plast Reconstr Aesthet Surg 2008;61:1425-37. [PMID: 18835232 DOI: 10.1016/j.bjps.2008.05.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
121 Sáenz-López P, Vazquez F, Cozar JM, Carretero R, Garrido F, Ruiz-Cabello F. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population. Hum Immunol 2013;74:98-103. [PMID: 23073296 DOI: 10.1016/j.humimm.2012.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
122 Formiga FR, Tamayo E, Simón-Yarza T, Pelacho B, Prósper F, Blanco-Prieto MJ. Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev 2012;17:449-73. [PMID: 21979836 DOI: 10.1007/s10741-011-9285-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
123 Macy ME, DeRyckere D, Gore L. Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents. Invest New Drugs 2012;30:468-79. [PMID: 21046425 DOI: 10.1007/s10637-010-9572-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
124 Wang J, Xiang Y, Jiang S, Li H, Caviezel F, Katawatin S, Duangjinda M. Involvement of the VEGF signaling pathway in immunosuppression and hypoxia stress: analysis of mRNA expression in lymphocytes mediating panting in Jersey cattle under heat stress. BMC Vet Res 2021;17:209. [PMID: 34098948 DOI: 10.1186/s12917-021-02912-y] [Reference Citation Analysis]
125 Barton S, Swanton C. Recent Developments in Treatment Stratification for Metastatic Breast Cancer: . Drugs 2011;71:2099-113. [DOI: 10.2165/11594480-000000000-00000] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
126 Nieto Y, Woods J, Nawaz F, Baron A, Jones RB, Shpall EJ, Nawaz S. Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer 2007;97:391-7. [PMID: 17609662 DOI: 10.1038/sj.bjc.6603875] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
127 Mukherjee S, Patra CR. Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale 2016;8:12444-70. [DOI: 10.1039/c5nr07887c] [Cited by in Crossref: 70] [Cited by in F6Publishing: 22] [Article Influence: 11.7] [Reference Citation Analysis]
128 Ribeiro LA, Bacci ML, Seren E, Tamanini C, Forni M. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol Reprod Dev 2007;74:163-71. [PMID: 16967516 DOI: 10.1002/mrd.20589] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
129 Eder M, Krivoshein AV, Backer M, Backer JM, Haberkorn U, Eisenhut M. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature. Nucl Med Biol 2010;37:405-12. [PMID: 20447550 DOI: 10.1016/j.nucmedbio.2010.02.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
130 Ha JM, Baek SH, Kim YH, Jin SY, Lee HS, Kim SJ, Shin HK, Lee DH, Song SH, Kim CD, Bae SS. Regulation of retinal angiogenesis by phospholipase C-β3 signaling pathway. Exp Mol Med 2016;48:e240. [PMID: 27311705 DOI: 10.1038/emm.2016.39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
131 Arcangeli A. Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk. American Journal of Physiology-Cell Physiology 2011;301:C762-71. [DOI: 10.1152/ajpcell.00113.2011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
132 Constable I, Shen W, Rakoczy E. Emerging biological therapies for age-related macula degeneration. Expert Opinion on Biological Therapy 2005;5:1373-85. [DOI: 10.1517/14712598.5.10.1373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
133 Binu S, Soumya SJ, Kumar VB, Sudhakaran PR. Poly-ADP-ribosylation of vascular endothelial growth factor and its implications on angiogenesis. Adv Exp Med Biol 2012;749:269-78. [PMID: 22695851 DOI: 10.1007/978-1-4614-3381-1_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
134 Fernandez-Alonso R, Martin-Lopez M, Gonzalez-Cano L, Garcia S, Castrillo F, Diez-Prieto I, Fernandez-Corona A, Lorenzo-Marcos ME, Li X, Claesson-Welsh L, Marques MM, Marin MC. p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling. Cell Death Differ 2015;22:1287-99. [PMID: 25571973 DOI: 10.1038/cdd.2014.214] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
135 Marini M, Bertolai R, Ambrosini S, Sarchielli E, Vannelli GB, Sgambati E. Differential expression of vascular endothelial growth factor in human fetal skeletal site-specific tissues: Mandible versus femur. Acta Histochemica 2015;117:228-34. [DOI: 10.1016/j.acthis.2015.02.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
136 Tulotta C, He S, van der Ent W, Chen L, Groenewoud A, Spaink HP, Snaar-Jagalska BE. Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model. Adv Exp Med Biol 2016;916:239-63. [PMID: 27165357 DOI: 10.1007/978-3-319-30654-4_11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
137 Rud’ko AS, Efendieva MK, Budzinskaya MV, Karpilova MA. Influence of vascular endothelial growth factor on angiogenesis and neurogenesis. Vestn oftal'mol 2017;133:75. [DOI: 10.17116/oftalma2017133375-80] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
138 Siekmann AF, Lawson ND. Notch signalling and the regulation of angiogenesis. Cell Adh Migr 2007;1:104-6. [PMID: 19329884 DOI: 10.4161/cam.1.2.4488] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
139 Cohen SY, Souied EH, Weber M, Dupeyron G, de Pouvourville G, Lievre M, Ponthieux A. Patient characteristics and treatment of neovascular age-related macular degeneration in France: the LUEUR1 observational study. Graefes Arch Clin Exp Ophthalmol 2011;249:521-7. [PMID: 21057805 DOI: 10.1007/s00417-010-1553-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
140 Ibrahim WS, Mohamed FSA, Abdel Samie EM, Moselhy WA, Mohamed AF. Assessment of anti-cancer potential of Hyalomma dromedarii salivary glands extract: in vitro study. Biologia 2021;76:1215-25. [DOI: 10.2478/s11756-020-00634-4] [Reference Citation Analysis]
141 Kazemi M, Carrer A, Moimas S, Zandonà L, Bussani R, Casagranda B, Palmisano S, Prelazzi P, Giacca M, Zentilin L, De Manzini N, Giacca M, Zacchigna S. VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans. Cancer Gene Ther 2016;23:125-32. [DOI: 10.1038/cgt.2016.12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
142 Chen F, Zhang H, Wang J. Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma. Bioengineered 2022;13:11551-63. [PMID: 35502885 DOI: 10.1080/21655979.2022.2068922] [Reference Citation Analysis]
143 Pietro L, Daher S, Rudge MV, Calderon IM, Damasceno DC, Sinzato YK, Bandeira C, Bevilacqua E. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta. 2010;31:770-780. [PMID: 20674013 DOI: 10.1016/j.placenta.2010.07.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
144 Mulcrone PL, Edwards SKE, Petrusca DN, Haneline LS, Delgado-Calle J, Roodman GD. Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23. Sci Rep 2020;10:17319. [PMID: 33057033 DOI: 10.1038/s41598-020-74352-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
145 Mele T, Generali D, Fox S, Brizzi MP, Bersiga A, Milani M, Allevi G, Bonardi S, Aguggini S, Volante M, Dogliotti L, Bottini A, Harris A, Berruti A. Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. Breast Cancer Res Treat 2010;123:795-804. [PMID: 20680681 DOI: 10.1007/s10549-010-1063-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
146 Samuel S, Fan F, Dang LH, Xia L, Gaur P, Ellis LM. Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells. Oncogene. 2011;30:1205-1212. [PMID: 21057529 DOI: 10.1038/onc.2010.496] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
147 Doi T, Matsubara N, Kawai A, Naka N, Takahashi S, Uemura H, Yamamoto N. Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors. Invest New Drugs 2020;38:1175-85. [PMID: 31820255 DOI: 10.1007/s10637-019-00859-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
148 Sundberg LM, Herrera JJ, Narayana PA. Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: in vivo longitudinal assessment. J Neurotrauma 2011;28:565-78. [PMID: 21299336 DOI: 10.1089/neu.2010.1533] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
149 Franco AT, Ware J. Pathophysiology 2: The Role of Platelets in Cancer Biology. Cancer Treat Res 2019;179:37-54. [PMID: 31317479 DOI: 10.1007/978-3-030-20315-3_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
150 Duda DG, Willett CG, Ancukiewicz M, di Tomaso E, Shah M, Czito BG, Bentley R, Poleski M, Lauwers GY, Carroll M. Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer. Oncologist. 2010;15:577-583. [PMID: 20484123 DOI: 10.1634/theoncologist.2010-0029] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
151 Savant SS, Sriramkumar S, O'Hagan HM. The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer. Cancers (Basel) 2018;10:E251. [PMID: 30061485 DOI: 10.3390/cancers10080251] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]
152 Qiu MZ, Xu RH. The progress of targeted therapy in advanced gastric cancer. Biomark Res. 2013;1:32. [PMID: 24330856 DOI: 10.1186/2050-7771-1-32] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
153 Han SW, Vergani CA, Reis PEO. Is gene therapy for limb ischemia a reality? J Vasc Bras 2020;19:e20190059. [PMID: 34178054 DOI: 10.1590/1677-5449.190059] [Reference Citation Analysis]
154 Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev. 2007;28:297-321. [PMID: 17409287 DOI: 10.1210/er.2006-0027] [Cited by in Crossref: 236] [Cited by in F6Publishing: 231] [Article Influence: 15.7] [Reference Citation Analysis]
155 Grothey E, Shrader M, Lee J. Highlights from: The 43rd Annual Meeting of the American Society of Clinical Oncology; Chicago, IL; June 1–5, 2007. Clinical Colorectal Cancer 2007;6:614-20. [DOI: 10.1016/s1533-0028(11)70300-0] [Reference Citation Analysis]
156 Wang F, Teng Z, Liu D, Wang Y, Lou J, Dong Z. β-Caryophyllene Liposomes Attenuate Neurovascular Unit Damage After Subarachnoid Hemorrhage in Rats. Neurochem Res 2020;45:1758-68. [PMID: 32444923 DOI: 10.1007/s11064-020-03037-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Vered M, Buchner A, Dayan D. Giant cell granuloma of the jawbones ? a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factor. J Oral Pathol Med 2006;35:613-9. [DOI: 10.1111/j.1600-0714.2006.00477.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
158 Ongay S, Puerta A, Díez-masa JC, Bergquist J, de Frutos M. Development of CE methods to analyze potential components of the angiogenic glycoprotein vascular endothelial growth factor 165. Electrophoresis 2009;30:315-24. [DOI: 10.1002/elps.200800140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
159 Portela-gomes GM, Grimelius L, Stridsberg M, Bresaola E, Viale G, Pelosi G. Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung. Virchows Arch 2005;446:604-12. [DOI: 10.1007/s00428-005-1222-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
160 Chen S, Le T, Harley BAC, Imoukhuede PI. Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification. Front Bioeng Biotechnol 2018;6:92. [PMID: 30050899 DOI: 10.3389/fbioe.2018.00092] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
161 Rotar IC, Dumitras DE, Popp RA, Petrisor FM, Cotutiu P, Stamatian F, Muresan D. VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia. Anal Cell Pathol (Amst) 2016;2016:6074275. [PMID: 27812483 DOI: 10.1155/2016/6074275] [Reference Citation Analysis]
162 Wang N, Chen H, Teng Y, Ding X, Wu H, Jin X. Artesunate inhibits proliferation and invasion of mouse hemangioendothelioma cells in vitro and of tumor growth in vivo. Oncol Lett 2017;14:6170-6. [PMID: 29113263 DOI: 10.3892/ol.2017.6986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
163 Porter AM, Klinge CM, Gobin AS. Covalently grafted VEGF(165) in hydrogel models upregulates the cellular pathways associated with angiogenesis. Am J Physiol Cell Physiol 2011;301:C1086-92. [PMID: 21795519 DOI: 10.1152/ajpcell.00090.2011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
164 Janani B, Vijayakumar M, Priya K, Kim JH, Prabakaran DS, Shahid M, Al-ghamdi S, Alsaidan M, Othman Bahakim N, Hassan Abdelzaher M, Ramesh T. EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges. Vaccines 2022;10:499. [DOI: 10.3390/vaccines10040499] [Reference Citation Analysis]
165 Bellou S, Hink MA, Bagli E, Panopoulou E, Bastiaens PI, Murphy C, Fotsis T. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. Am J Physiol Cell Physiol 2009;297:C1477-89. [PMID: 19741200 DOI: 10.1152/ajpcell.00058.2009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
166 Aroui S, Fetoui H, Kenani A. Natural dietary compound naringin inhibits glioblastoma cancer neoangiogenesis. BMC Pharmacol Toxicol 2020;21:46. [PMID: 32576255 DOI: 10.1186/s40360-020-00426-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
167 Martorana A, La Monica G, Lauria A. Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways. Molecules 2020;25:E4279. [PMID: 32961977 DOI: 10.3390/molecules25184279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Tafuro S, Ayuso E, Zacchigna S, Zentilin L, Moimas S, Dore F, Giacca M. Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression. Cardiovascular Research 2009;83:663-71. [DOI: 10.1093/cvr/cvp152] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
169 Tjakra M, Wang Y, Vania V, Hou Z, Durkan C, Wang N, Wang G. Overview of Crosstalk Between Multiple Factor of Transcytosis in Blood Brain Barrier. Front Neurosci 2019;13:1436. [PMID: 32038141 DOI: 10.3389/fnins.2019.01436] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
170 Lazzari G, Silvano G. From Anemia to Erythropoietin Resistance in Head and Neck Squamous Cell Carcinoma Treatment: A Carousel Driven by Hypoxia. Onco Targets Ther 2020;13:841-51. [PMID: 32099388 DOI: 10.2147/OTT.S242263] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
171 Dondossola E, Holzapfel BM, Alexander S, Filippini S, Hutmacher DW, Friedl P. Examination of the foreign body response to biomaterials by nonlinear intravital microscopy. Nat Biomed Eng 2016;1:0007. [PMID: 28979821 DOI: 10.1038/s41551-016-0007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 12.5] [Reference Citation Analysis]
172 Jin X. Cellular and molecular basis of antibody-dependent enhancement in human dengue pathogenesis. Future Virology 2008;3:343-61. [DOI: 10.2217/17460794.3.4.343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
173 Missiaen R, Mazzone M, Bergers G. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer. Semin Cancer Biol 2018;52:107-16. [PMID: 29935312 DOI: 10.1016/j.semcancer.2018.06.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
174 Song KD, Choi D, Lee JH, Im GH, Yang J, Kim JH, Lee WJ. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma. AJR Am J Roentgenol 2014;202:W559-66. [PMID: 24848850 DOI: 10.2214/AJR.13.11042] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
175 Hong J, Min Y, Wuest T, Lin PC. Vav1 is Essential for HIF-1α Activation via a Lysosomal VEGFR1-Mediated Degradation Mechanism in Endothelial Cells. Cancers (Basel) 2020;12:E1374. [PMID: 32471123 DOI: 10.3390/cancers12061374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 de Oliveira MVM, Pereira Gomes ÉP, Pereira CS, de Souza LR, Barros LO, Mendes DC, S. Guimarães AL, De Paula AMB. Prognostic Value of Microvessel Density and p53 Expression on the Locoregional Metastasis and Survival of the Patients With Head and Neck Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2013;21:444-51. [DOI: 10.1097/pai.0b013e3182773125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
177 Chen X, Gao Y, Zhang G, Li B, Ma T, Ma Y, Wang X. Bevacizumab Plays a double-edged role in Neoadjuvant Therapy for Non-metastatic Breast Cancer: A Systemic Review and Meta-Analysis. J Cancer 2021;12:2643-53. [PMID: 33854624 DOI: 10.7150/jca.53303] [Reference Citation Analysis]
178 Sun J, Huang W, Yang SF, Zhang XP, Yu Q, Zhang ZQ, Yao J, Li KR, Jiang Q, Cao C. Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. Theranostics 2018;8:4695-709. [PMID: 30279732 DOI: 10.7150/thno.26203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
179 Ferroni M, De Gaetano F, Cereda MG, Boschetti F. Evaluation of the ocular fluid dynamic effects on intraocular magnesium-based device: A comparison between CFD and FSI approaches. Med Eng Phys 2020;86:20-8. [PMID: 33261729 DOI: 10.1016/j.medengphy.2020.10.004] [Reference Citation Analysis]
180 Novodvorsky P, Chico TJ. The Role of the Transcription Factor KLF2 in Vascular Development and Disease. Genetics of Cardiovascular Disease. Elsevier; 2014. pp. 155-88. [DOI: 10.1016/b978-0-12-386930-2.00007-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
181 Ytrehus B, Haga HA, Mellum CN, Mathisen L, Carlson CS, Ekman S, Teige J, Reinholt FP. Experimental ischemia of porcine growth cartilage produces lesions of osteochondrosis. J Orthop Res 2004;22:1201-9. [DOI: 10.1016/j.orthres.2004.03.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
182 Javorkova E, Vackova J, Hajkova M, Hermankova B, Zajicova A, Holan V, Krulova M. The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells. Biomed Pharmacother 2018;97:402-11. [PMID: 29091890 DOI: 10.1016/j.biopha.2017.10.114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
183 Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 2007;144:627-37. [PMID: 17893015 DOI: 10.1016/j.ajo.2007.06.039] [Cited by in Crossref: 137] [Cited by in F6Publishing: 117] [Article Influence: 9.1] [Reference Citation Analysis]
184 He YC, Halford MM, Achen MG, Stacker SA. Exploring the role of endothelium in the tumour response to anti-angiogenic therapy. Biochem Soc Trans 2014;42:1569-75. [PMID: 25399572 DOI: 10.1042/BST20140173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
185 Abdelhafez OM, Ali HI, Amin KM, Abdalla MM, Ahmed EY. Design, synthesis and anticancer activity of furochromone and benzofuran derivatives targeting VEGFR-2 tyrosine kinase. RSC Adv 2015;5:25312-24. [DOI: 10.1039/c4ra16228e] [Cited by in Crossref: 17] [Article Influence: 2.4] [Reference Citation Analysis]
186 Lee YW, Cho HJ, Lee WH, Sonntag WE. Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets. Biomol Ther (Seoul) 2012;20:357-70. [PMID: 24009822 DOI: 10.4062/biomolther.2012.20.4.357] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
187 Dai B, Zhang Y, Zhan Y, Zhang D, Wang N, He L. A novel tissue model for angiogenesis: evaluation of inhibitors or promoters in tissue level. Sci Rep 2014;4:3693. [PMID: 24424154 DOI: 10.1038/srep03693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
188 Li YH, Hu CF, Shao Q, Huang MY, Hou JH, Xie D, Zeng YX, Shao JY. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med. 2008;6:1. [PMID: 18171482 DOI: 10.1186/1479-5876-6-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
189 Vassilopoulos A, Deng CX, Chavakis T. Crosstalk between the DNA damage response, histone modifications and neovascularisation. Int J Biochem Cell Biol 2010;42:193-7. [PMID: 19945543 DOI: 10.1016/j.biocel.2009.11.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
190 Koukourakis GV, Sotiropoulou-Lontou A. Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer. Clin Transl Oncol 2011;13:710-4. [PMID: 21975331 DOI: 10.1007/s12094-011-0720-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
191 Gordon MS. Antiangiogenic therapies: is VEGF-A inhibition alone enough? Expert Rev Anticancer Ther 2011;11:485-96. [PMID: 21417860 DOI: 10.1586/era.11.5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
192 Guerreiro SG, Oliveira MJ, Barbosa MA, Soares R, Granja PL. Neonatal Human Dermal Fibroblasts Immobilized in RGD–Alginate Induce Angiogenesis. Cell Transplant 2014;23:945-57. [DOI: 10.3727/096368913x670183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
193 Guo L, Zou K, Ju J, Xie H. Hyaluronan Promotes Tumor Lymphangiogenesis and Intralymphantic Tumor Growth in Xenografts. Acta Biochim Biophys Sinica 2005;37:601-6. [DOI: 10.1111/j.1745-7270.2005.00083.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
194 Paule B, Bastien L, Deslandes E, Cussenot O, Podgorniak MP, Allory Y, Naïmi B, Porcher R, de La Taille A, Menashi S, Calvo F, Mourah S. Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas. PLoS One 2010;5:e10715. [PMID: 20502715 DOI: 10.1371/journal.pone.0010715] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
195 Gomułka K, Liebhart J, Lange A, Mêdrala W. Vascular endothelial growth factor-activated basophils in asthmatics. Postepy Dermatol Alergol 2020;37:584-9. [PMID: 32994783 DOI: 10.5114/ada.2020.95954] [Reference Citation Analysis]
196 Haase K, Kamm RD. Advances in on-chip vascularization. Regen Med. 2017;12:285-302. [PMID: 28318376 DOI: 10.2217/rme-2016-0152] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 13.2] [Reference Citation Analysis]
197 Chao TL, Gu SY, Lin PH, Chou YT, Ling TY, Chang SY. Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells. Front Microbiol 2019;10:2942. [PMID: 32038512 DOI: 10.3389/fmicb.2019.02942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Reddy SK, Morse MA, Hurwitz HI, Bendell JC, Gan TJ, Hill SE, Clary BM. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg. 2008;206:96-106. [PMID: 18155574 DOI: 10.1016/j.jamcollsurg.2007.06.290] [Cited by in Crossref: 138] [Cited by in F6Publishing: 110] [Article Influence: 9.2] [Reference Citation Analysis]
199 Mourah S, Porcher R, Lescaille G, Rousselot P, Podgorniak M, Labarchède G, Naïmi B, Medioni J, Dombret H, Calvo F. Quantification of VEGF Isoforms and VEGFR Transcripts by qRT-PCR and Their Significance in Acute Myeloid Leukemia. Int J Biol Markers 2009;24:22-31. [DOI: 10.1177/172460080902400104] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
200 Shusterman S, Maris JM. Prospects for therapeutic inhibition of neuroblastoma angiogenesis. Cancer Letters 2005;228:171-9. [DOI: 10.1016/j.canlet.2005.01.049] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
201 Yu P, Passam FH, Yu DM, Denyer G, Krilis SA. Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost 2008;6:1215-23. [PMID: 18452581 DOI: 10.1111/j.1538-7836.2008.03000.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
202 de la Torre E, Hovsepian E, Penas FN, Dmytrenko G, Castro ME, Goren NB, Sales ME. Macrophages derived from septic mice modulate nitric oxide synthase and angiogenic mediators in the heart. J Cell Physiol 2013;228:1584-93. [PMID: 23335284 DOI: 10.1002/jcp.24320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
203 Sobacchi C, Palagano E, Villa A, Menale C. Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate. Front Bioeng Biotechnol. 2017;5:32. [PMID: 28567372 DOI: 10.3389/fbioe.2017.00032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
204 Kim GY, Lee JW, Cho SH, Seo JM, Kim JH. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29:915-920. [PMID: 19286633 DOI: 10.1161/atvbaha.109.185793] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
205 Sepe P, Martinetti A, Mennitto A, Verzoni E, Claps M, Raimondi A, Sottotetti E, Grassi P, Guadalupi V, Stellato M, Zattarin E, Di Maio M, Procopio G. Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study). Am J Clin Oncol 2020;43:621-7. [PMID: 32889831 DOI: 10.1097/COC.0000000000000719] [Reference Citation Analysis]
206 Skerra A. Alternative binding proteins: Anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities: Anticalins. FEBS Journal 2008;275:2677-83. [DOI: 10.1111/j.1742-4658.2008.06439.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 8.6] [Reference Citation Analysis]
207 Christensen A, Haresign W, Khalid M. Progesterone exposure of seasonally anoestrous ewes alters the expression of angiogenic growth factors in preovulatory follicles. Theriogenology 2014;81:358-67. [DOI: 10.1016/j.theriogenology.2013.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
208 Atzori MG, Tentori L, Ruffini F, Ceci C, Bonanno E, Scimeca M, Lacal PM, Graziani G. The Anti–Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. J Pharmacol Exp Ther 2017;364:77-86. [DOI: 10.1124/jpet.117.244434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
209 Clemente M, Pérez-alenza MD, Illera JC, Peña L. Histological, Immunohistological, and Ultrastructural Description of Vasculogenic Mimicry in Canine Mammary Cancer. Vet Pathol 2010;47:265-74. [DOI: 10.1177/0300985809353167] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 5.7] [Reference Citation Analysis]
210 Cohen MP, Hud E, Shea E, Shearman CW. Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy. Ophthalmic Res 2008;40:5-9. [PMID: 18025835 DOI: 10.1159/000111151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
211 Larsen AK, de Gramont A, Poindessous V, Bouygues A, Ayadi M, Mésange P. Functions and Clinical Implications of Autocrine VEGF Signaling in Colorectal Cancer. Curr Colorectal Cancer Rep 2013;9:270-7. [DOI: 10.1007/s11888-013-0177-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
212 Bender JLG, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ. Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study. JCO 2008;26:399-405. [DOI: 10.1200/jco.2007.11.9230] [Cited by in Crossref: 182] [Cited by in F6Publishing: 81] [Article Influence: 13.0] [Reference Citation Analysis]
213 Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst. 2008;100:109-120. [PMID: 18182619 DOI: 10.1093/jnci/djm279] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 8.3] [Reference Citation Analysis]
214 Horta BAC, Cirino JJV, de Alencastro RB. Dynamical behavior of the vascular endothelial growth factor: Biological implications. Proteins 2007;67:517-25. [DOI: 10.1002/prot.21306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
215 Wheeler C, Stephens T, Byth K, Green T, Wedge S, Blakey D, Hughes A. Novel approaches in oncology at AstraZeneca. European Journal of Cancer Supplements 2003;1:3-8. [DOI: 10.1016/s1359-6349(03)80014-9] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
216 Wei XN, Han BC, Zhang JX, Liu XH, Tan CY, Jiang YY, Low BC, Tidor B, Chen YZ. An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability. BMC Syst Biol 2011;5:112. [PMID: 21756365 DOI: 10.1186/1752-0509-5-112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
217 Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, Lieberman AP, Breedlove SM, Jordan CL. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A 2007;104:18259-64. [PMID: 17984063 DOI: 10.1073/pnas.0705501104] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 7.3] [Reference Citation Analysis]
218 Rajagopalan M, Balasubramanian S, Ramaswamy A, Mathur PP. Pharmacophore based 3D-QSAR modeling and free energy analysis of VEGFR-2 inhibitors. J Enzyme Inhib Med Chem 2013;28:1236-46. [PMID: 23061928 DOI: 10.3109/14756366.2012.729826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
219 Shimamura M, Nakagami H, Koriyama H, Morishita R. Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease. Biomed Res Int 2013;2013:186215. [PMID: 24294599 DOI: 10.1155/2013/186215] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
220 Casagrande L, Cordeiro MM, Nör SA, Nör JE. Dental pulp stem cells in regenerative dentistry. Odontology 2011;99:1-7. [DOI: 10.1007/s10266-010-0154-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
221 Mozafarihashjin M, Togha M, Ghorbani Z, Farbod A, Rafiee P, Martami F. Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2. J Headache Pain 2022;23:3. [PMID: 34991456 DOI: 10.1186/s10194-021-01377-6] [Reference Citation Analysis]
222 Manickam V, Tiwari A, Jung JJ, Bhattacharya R, Goel A, Mukhopadhyay D, Choudhury A. Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood 2011;117:1425-35. [PMID: 21063020 DOI: 10.1182/blood-2010-06-291690] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
223 Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, Christofori G, Héroult M, Augustin HG, Ponta H. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood. 2009;114:5236-5244. [PMID: 19773544 DOI: 10.1182/blood-2009-04-219204] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 8.3] [Reference Citation Analysis]
224 Guerra Dore CMP, Faustino Alves MGC, Santos ND, Cruz AKM, Câmara RBG, Castro AJG, Guimarães Alves L, Nader HB, Lisboa Leite E. Antiangiogenic activity and direct antitumor effect from a sulfated polysaccharide isolated from seaweed. Microvascular Research 2013;88:12-8. [DOI: 10.1016/j.mvr.2013.03.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
225 Le Roux S, Pepper RJ, Dufay A, Néel M, Meffray E, Lamandé N, Rimbert M, Josien R, Hamidou M, Hourmant M, Cook HT, Charreau B, Larger E, Salama AD, Fakhouri F. Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 2012;23:155-64. [PMID: 22034638 DOI: 10.1681/ASN.2010080858] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
226 Guo S, Martin MG, Tian C, Cui J, Wang L, Wu S, Gu W. Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer. J Cancer 2018;9:1287-300. [PMID: 29675110 DOI: 10.7150/jca.22020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
227 Song Z, Yang Z, Yang J, Liu Z, Peng Z, Tang R, Gu Y. Repair of abdominal wall defects in vitro and in vivo using VEGF sustained-release multi-walled carbon nanotubes (MWNT) composite scaffolds. PLoS One 2013;8:e64358. [PMID: 23717603 DOI: 10.1371/journal.pone.0064358] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
228 Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012;22:146-57. [PMID: 22264731 DOI: 10.1016/j.devcel.2011.11.002] [Cited by in Crossref: 222] [Cited by in F6Publishing: 207] [Article Influence: 22.2] [Reference Citation Analysis]
229 Corrie PG, Basu B, Zaki KA. Targeting angiogenesis in melanoma: prospects for the future. Ther Adv Med Oncol 2010;2:367-80. [PMID: 21789148 DOI: 10.1177/1758834010380101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
230 Qi JH, Bell B, Singh R, Batoki J, Wolk A, Cutler A, Prayson N, Ali M, Stoehr H, Anand-Apte B. Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism. Sci Rep 2019;9:17429. [PMID: 31757977 DOI: 10.1038/s41598-019-53433-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
231 Norman JT. Protecting the microvasculature: a Tie-ght connection to ameliorating chronic kidney disease? J Am Soc Nephrol 2006;17:2353-5. [PMID: 16899514 DOI: 10.1681/ASN.2006070741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
232 Iivanainen E, Paatero I, Heikkinen S, Junttila TT, Cao R, Klint P, Jaakkola PM, Cao Y, Elenius K. Intra- and extracellular signaling by endothelial neuregulin-1. Experimental Cell Research 2007;313:2896-909. [DOI: 10.1016/j.yexcr.2007.03.042] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
233 Czepluch FS, Vogler M, Kuschicke H, Meier J, Gogiraju R, Katschinski DM, Riggert J, Hasenfuss G, Schäfer K. Circulating Endothelial Cells Expressing the Angiogenic Transcription Factor Krüppel-Like Factor 4 are Decreased in Patients with Coronary Artery Disease. Microcirculation 2015;22:700-10. [DOI: 10.1111/micc.12226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
234 Xia L, Lin K, Jiang X, Fang B, Xu Y, Liu J, Zeng D, Zhang M, Zhang X, Chang J, Zhang Z. Effect of nano-structured bioceramic surface on osteogenic differentiation of adipose derived stem cells. Biomaterials 2014;35:8514-27. [DOI: 10.1016/j.biomaterials.2014.06.028] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 15.1] [Reference Citation Analysis]
235 Zengin H, Kaplan S, Tümkaya L, Altunkaynak BZ, Rağbetli MÇ, Altunkaynak ME, Yılmaz Ö. Effect of prenatal exposure to diclofenac sodium on the male rat arteries: a stereological and histopathological study. Drug and Chemical Toxicology 2011;36:67-78. [DOI: 10.3109/01480545.2011.649287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
236 Nair J, Ghatge M, Kakkar VV, Shanker J. Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease. PLoS One 2014;9:e94328. [PMID: 24736319 DOI: 10.1371/journal.pone.0094328] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
237 Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, Lee PJ, Geick A, de Fougerolles AR, Elias JA. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006;12:1286-93. [PMID: 17086189 DOI: 10.1038/nm1494] [Cited by in Crossref: 237] [Cited by in F6Publishing: 226] [Article Influence: 14.8] [Reference Citation Analysis]
238 Morita J, Nakamura M, Kobayashi Y, Deng CX, Funato N, Moriyama K. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model. Dev Dyn 2014;243:560-7. [PMID: 24259495 DOI: 10.1002/dvdy.24099] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
239 Heyman HR, Frey RR, Bousquet PF, Cunha GA, Moskey MD, Ahmed AA, Soni NB, Marcotte PA, Pease LJ, Glaser KB, Yates M, Bouska JJ, Albert DH, Black-schaefer CL, Dandliker PJ, Stewart KD, Rafferty P, Davidsen SK, Michaelides MR, Curtin ML. Thienopyridine urea inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters 2007;17:1246-9. [DOI: 10.1016/j.bmcl.2006.12.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
240 Roy M, Luo YH, Ye M, Liu J. Nonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitors. Biomed Res Int 2013;2013:964743. [PMID: 23936861 DOI: 10.1155/2013/964743] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
241 Edwards DJ, Hadfield JA, Wallace TW, Ducki S. Tubulin-binding dibenz[c,e]oxepines as colchinol analogues for targeting tumour vasculature. Org Biomol Chem 2011;9:219-31. [DOI: 10.1039/c0ob00500b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
242 Song JW, Munn LL. Fluid forces control endothelial sprouting. Proc Natl Acad Sci U S A 2011;108:15342-7. [PMID: 21876168 DOI: 10.1073/pnas.1105316108] [Cited by in Crossref: 322] [Cited by in F6Publishing: 284] [Article Influence: 29.3] [Reference Citation Analysis]
243 Zips D, Hessel F, Krause M, Schiefer Y, Hoinkis C, Thames HD, Haberey M, Baumann M. Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice. International Journal of Radiation Oncology*Biology*Physics 2005;61:908-14. [DOI: 10.1016/j.ijrobp.2004.11.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
244 Hayran Y, Lay I, Mocan MC, Bozduman T, Ersoy-evans S. Vascular endothelial growth factor gene polymorphisms in patients with rosacea: A case-control study. Journal of the American Academy of Dermatology 2019;81:348-54. [DOI: 10.1016/j.jaad.2019.03.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
245 Ma A, Biersack B, Goehringer N, Nitzsche B, Höpfner M. Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma. JPM 2022;12:738. [DOI: 10.3390/jpm12050738] [Reference Citation Analysis]
246 Sideras K, Dueck AC, Hobday TJ, Rowland KM Jr, Allred JB, Northfelt DW, Lingle WL, Behrens RJ, Fitch TR, Nikcevich DA, Perez EA. North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane. Clin Breast Cancer 2012;12:387-91. [PMID: 23083501 DOI: 10.1016/j.clbc.2012.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
247 Zeng L, Xiao Q, Margariti A, Zhang Z, Zampetaki A, Patel S, Capogrossi MC, Hu Y, Xu Q. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol. 2006;174:1059-1069. [PMID: 16982804 DOI: 10.1083/jcb.200605113] [Cited by in Crossref: 185] [Cited by in F6Publishing: 171] [Article Influence: 11.6] [Reference Citation Analysis]
248 Sambyal V, Guleria K, Kapahi R, Manjari M, Sudan M, Uppal MS, Singh NR. Association of VEGF haplotypes with breast cancer risk in North-West Indians. BMC Med Genomics 2021;14:209. [PMID: 34429108 DOI: 10.1186/s12920-021-01060-4] [Reference Citation Analysis]
249 Chen J, Liu J, Xu B, Cao Y, Liang X, Wu F, Shen X, Ma X, Liu J. Ethoxy-erianin phosphate and afatinib synergistically inhibit liver tumor growth and angiogenesis via regulating VEGF and EGFR signaling pathways. Toxicol Appl Pharmacol 2022;:115911. [PMID: 35143806 DOI: 10.1016/j.taap.2022.115911] [Reference Citation Analysis]
250 Wang N, Wang ZY, Mo SL, Loo TY, Wang DM, Luo HB, Yang DP, Chen YL, Shen JG, Chen JP. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res Treat 2012;134:943-55. [PMID: 22350787 DOI: 10.1007/s10549-012-1977-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 10.1] [Reference Citation Analysis]
251 Roviello G, Conca R, D'Angelo A, Multari AG, Paganini G, Chiriacò G, Petrioli R, Corona SP, Rosellini P, Aieta M. Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer. Anticancer Drugs 2020;31:632-6. [PMID: 32011363 DOI: 10.1097/CAD.0000000000000905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
252 Yi T, Yi Z, Cho SG, Luo J, Pandey MK, Aggarwal BB, Liu M. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res. 2008;68:1843-1850. [PMID: 18339865 DOI: 10.1158/0008-5472.CAN-07-5944] [Cited by in Crossref: 175] [Cited by in F6Publishing: 67] [Article Influence: 12.5] [Reference Citation Analysis]
253 Salvati E, Zizza P, Rizzo A, Iachettini S, Cingolani C, D'Angelo C, Porru M, Randazzo A, Pagano B, Novellino E, Pisanu ME, Stoppacciaro A, Spinella F, Bagnato A, Gilson E, Leonetti C, Biroccio A. Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis. Nucleic Acids Res 2014;42:2945-57. [PMID: 24335081 DOI: 10.1093/nar/gkt1289] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
254 Garcia V, Garcia JM, Silva J, Peña C, Dominguez G, Lorenzo Y, Diaz R, Alonso I, Colas A, Hurtado A, Sanchez A, Bonilla F. Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis. J Cancer Res Clin Oncol 2008;134:1165-71. [PMID: 18461364 DOI: 10.1007/s00432-008-0405-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
255 Vadakara J, Borghaei H. Personalized medicine and treatment approaches in non-small-cell lung carcinoma. Pharmgenomics Pers Med 2012;5:113-23. [PMID: 23226067 DOI: 10.2147/PGPM.S24258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
256 Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouysségur J, Yaniv M, Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004;118:781-94. [PMID: 15369676 DOI: 10.1016/j.cell.2004.08.025] [Cited by in F6Publishing: 379] [Reference Citation Analysis]
257 García-aranda MI, González-lópez S, Santiveri CM, Gagey-eilstein N, Reille-seroussi M, Martín-martínez M, Inguimbert N, Vidal M, García-lópez MT, Jiménez MA, González-muñiz R, Pérez de Vega MJ. Helical peptides from VEGF and Vammin hotspots for modulating the VEGF–VEGFR interaction. Org Biomol Chem 2013;11:1896. [DOI: 10.1039/c3ob27312a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
258 Wittko-Schneider IM, Schneider FT, Plate KH. Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind. Cell Mol Life Sci 2013;70:1705-25. [PMID: 23475067 DOI: 10.1007/s00018-013-1279-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
259 Okada K, Yamasaki K, Tanaka C, Fujisaki H, Osugi Y, Hara J. Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent/refractory solid tumors. Jpn J Clin Oncol 2013;43:1073-9. [PMID: 24002900 DOI: 10.1093/jjco/hyt124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
260 Mehnert JM, McCarthy MM, Jilaveanu L, Flaherty KT, Aziz S, Camp RL, Rimm DL, Kluger HM. Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays. Hum Pathol. 2010;41:375-384. [PMID: 20004943 DOI: 10.1016/j.humpath.2009.08.016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
261 Li F, Jiang S, Zu Y, Lee DY, Li Z. A Tyrosine Kinase Inhibitor–Based High-Affinity PET Radiopharmaceutical Targets Vascular Endothelial Growth Factor Receptor. J Nucl Med 2014;55:1525-31. [DOI: 10.2967/jnumed.114.138925] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
262 Schiffelers RM, van der Vaart TK, Storm G. Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals. BioDrugs 2011;25:171-89. [PMID: 21627341 DOI: 10.2165/11589330-000000000-00000] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Ellenberger C, Müller K, Schoon HA, Wilsher S, Allen WR. Histological and immunohistochemical characterization of equine anovulatory haemorrhagic follicles (AHFs). Reprod Domest Anim 2009;44:395-405. [PMID: 18954391 DOI: 10.1111/j.1439-0531.2008.01085.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
264 Loutrari H, Hatziapostolou M, Skouridou V, Papadimitriou E, Roussos C, Kolisis FN, Papapetropoulos A. Perillyl alcohol is an angiogenesis inhibitor. J Pharmacol Exp Ther 2004;311:568-75. [PMID: 15210838 DOI: 10.1124/jpet.104.070516] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
265 García JR, Clark AY, García AJ. Integrin-specific hydrogels functionalized with VEGF for vascularization and bone regeneration of critical-size bone defects. J Biomed Mater Res A 2016;104:889-900. [PMID: 26662727 DOI: 10.1002/jbm.a.35626] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
266 Heo JW, Kim JH, Cho CS, Jun HO, Kim DH, Yu YS, Kim JH. Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells. PLoS One 2012;7:e33456. [PMID: 22457763 DOI: 10.1371/journal.pone.0033456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
267 Hall AP, Westwood FR, Wadsworth PF. Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate. Toxicol Pathol 2006;34:131-47. [DOI: 10.1080/01926230600611836] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
268 Wang JZ, Lin V, Toumi E, Wang K, Zhu H, Conway RM, Madigan MC, Murray M, Cherepanoff S, Zhou F, Shu W. Development of new therapeutic options for the treatment of uveal melanoma. FEBS J 2021. [PMID: 33838075 DOI: 10.1111/febs.15869] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
269 Giannaccare G, Pellegrini M, Bovone C, Spena R, Senni C, Scorcia V, Busin M. Anti-VEGF Treatment in Corneal Diseases. Curr Drug Targets 2020;21:1159-80. [PMID: 32189591 DOI: 10.2174/1389450121666200319111710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
270 Stinchcombe TE, Socinski MA. Bevacizumab in the treatment of non-small-cell lung cancer. Oncogene 2007;26:3691-8. [PMID: 17530022 DOI: 10.1038/sj.onc.1210366] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
271 Jensen LD, Nakamura M, Bräutigam L, Li X, Liu Y, Samani NJ, Cao Y. VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish. Proc Natl Acad Sci U S A 2015;112:E5944-53. [PMID: 26483474 DOI: 10.1073/pnas.1510245112] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
272 Savas P, Hughes B, Solomon B. Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer. J Thorac Dis 2013;5 Suppl 5:S579-92. [PMID: 24163750 DOI: 10.3978/j.issn.2072-1439.2013.08.52] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
273 Sato K, Meng F, Giang T, Glaser S, Alpini G. Mechanisms of cholangiocyte responses to injury. Biochim Biophys Acta Mol Basis Dis 2018;1864:1262-9. [PMID: 28648950 DOI: 10.1016/j.bbadis.2017.06.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
274 Schaffhauser B, Veikkola T, Strittmatter K, Antoniadis H, Alitalo K, Christofori G. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice. Journal of Leukocyte Biology 2006;80:669-76. [DOI: 10.1189/jlb.1105644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
275 Chan KC, Ho HH, Lin MC, Yen CH, Huang CN, Huang HP, Wang CJ. Mulberry water extracts inhibit atherosclerosis through suppression of the integrin-β₃/focal adhesion kinase complex and downregulation of nuclear factor κB signaling in vivo and in vitro. J Agric Food Chem 2014;62:9463-71. [PMID: 25197764 DOI: 10.1021/jf502942r] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
276 Saberi-karimian M, Katsiki N, Caraglia M, Boccellino M, Majeed M, Sahebkar A. Vascular endothelial growth factor: An important molecular target of curcumin. Critical Reviews in Food Science and Nutrition 2017;59:299-312. [DOI: 10.1080/10408398.2017.1366892] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
277 Badv M, Bayat F, Weitz JI, Didar TF. Single and multi-functional coating strategies for enhancing the biocompatibility and tissue integration of blood-contacting medical implants. Biomaterials 2020;258:120291. [PMID: 32798745 DOI: 10.1016/j.biomaterials.2020.120291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
278 Kaya M, Çokakli M, Berk AT, Yaman A, Yesilirmak D, Kumral A, Atabey N. Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity. Curr Eye Res 2013;38:137-42. [PMID: 23094709 DOI: 10.3109/02713683.2012.731550] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
279 Chellappan DK, Leng KH, Jia LJ, Aziz NABA, Hoong WC, Qian YC, Ling FY, Wei GS, Ying T, Chellian J, Gupta G, Dua K. The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review. Biomedicine & Pharmacotherapy 2018;102:1127-44. [DOI: 10.1016/j.biopha.2018.03.061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
280 Li JW, Wang JY, Yu RQ, Huo L, Zheng LW. Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid. BMC Res Notes 2022;15:12. [PMID: 35012647 DOI: 10.1186/s13104-021-05900-5] [Reference Citation Analysis]
281 Na II, Park JH, Choe du H, Lee JK, Koh JS. Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer. ISRN Oncol 2011;2011:756265. [PMID: 22091430 DOI: 10.5402/2011/756265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
282 Zhou H, Liang B, Jiang H, Deng Z, Yu K. Magnesium-based biomaterials as emerging agents for bone repair and regeneration: from mechanism to application. Journal of Magnesium and Alloys 2021;9:779-804. [DOI: 10.1016/j.jma.2021.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
283 Mohan A, Ponnusankar S. Newer therapies for the treatment of metastatic breast cancer: a clinical update. Indian J Pharm Sci 2013;75:251-61. [PMID: 24082340 DOI: 10.4103/0250-474X.117396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
284 Liu X, Zheng N, Shi Y, Yuan J, Li L. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway. Journal of Molecular Endocrinology 2014;52:245-54. [DOI: 10.1530/jme-13-0252] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
285 Sefcik LS, Wilson JL, Papin JA, Botchwey EA. Harnessing systems biology approaches to engineer functional microvascular networks. Tissue Eng Part B Rev 2010;16:361-70. [PMID: 20121415 DOI: 10.1089/ten.TEB.2009.0611] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
286 Shimizu K, Asai T, Oku N. Antineovascular therapy, a novel antiangiogenic approach. Expert Opinion on Therapeutic Targets 2005;9:63-76. [DOI: 10.1517/14728222.9.1.63] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
287 Duan J, Yu Y, Li Y, Yu Y, Sun Z. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 2013;34:5853-62. [PMID: 23663927 DOI: 10.1016/j.biomaterials.2013.04.032] [Cited by in Crossref: 124] [Cited by in F6Publishing: 124] [Article Influence: 13.8] [Reference Citation Analysis]
288 Tsai JH, Lee WM. Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy. Mol Cancer Res 2009;7:300-10. [PMID: 19276184 DOI: 10.1158/1541-7786.MCR-08-0215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
289 Liu C, Zhang N. Emerging biotechnological strategies for non-viral antiangiogenic gene therapy. Angiogenesis 2012;15:521-42. [DOI: 10.1007/s10456-012-9295-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
290 Weinandy S, Babczyk P, Dreier A, Unger RE, Flanagan TC, Kirkpatrick CJ, Zenke M, Klee D, Jockenhoevel S. Ovine carotid artery-derived cells as an optimized supportive cell layer in 2-D capillary network assays. PLoS One 2014;9:e91664. [PMID: 24621607 DOI: 10.1371/journal.pone.0091664] [Reference Citation Analysis]
291 He W, Tang Y, Qi B, Lu C, Qin C, Wei Y, Yi J, Chen M. Phylogenetic analysis and positive-selection site detecting of vascular endothelial growth factor family in vertebrates. Gene 2014;535:345-52. [PMID: 24200960 DOI: 10.1016/j.gene.2013.10.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
292 Lkhagvadorj S, Oh SS, Lee MR, Jung JH, Chung HC, Cha SK, Eom M. VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma. J Lifestyle Med 2014;4:64-70. [PMID: 26064856 DOI: 10.15280/jlm.2014.4.1.64] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
293 Kogan AA, Lapidus RG, Baer MR, Rassool FV. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment. Adv Cancer Res 2019;141:213-53. [PMID: 30691684 DOI: 10.1016/bs.acr.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
294 Zhang W, Yang Y, Cui B. New perspectives on the roles of nanoscale surface topography in modulating intracellular signaling. Curr Opin Solid State Mater Sci 2021;25:100873. [PMID: 33364912 DOI: 10.1016/j.cossms.2020.100873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
295 Agarwal S, Harter ZJ, Krishnamachary B, Chen L, Nguyen T, Voelkel NF, Dhillon NK. Sugen-morphine model of pulmonary arterial hypertension. Pulm Circ 2020;10:2045894019898376. [PMID: 32110385 DOI: 10.1177/2045894019898376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
296 Curradi G, Walters MS, Ding BS, Rafii S, Hackett NR, Crystal RG. Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells. Cell Mol Life Sci 2012;69:2217-31. [PMID: 22382924 DOI: 10.1007/s00018-012-0922-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
297 Yi JM, Park JS, Oh SM, Lee J, Kim J, Oh DS, Bang OS, Kim NS. Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo. BMC Complement Altern Med 2012;12:243. [PMID: 23206527 DOI: 10.1186/1472-6882-12-243] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
298 Iyer S, Scotney PD, Nash AD, Ravi Acharya K. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding. J Mol Biol 2006;359:76-85. [PMID: 16616187 DOI: 10.1016/j.jmb.2006.03.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
299 Jafari M, Abbruzzese JL. Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal intergroup pancreatic cancer task force. Surgical Oncology Clinics of North America 2004;13:751-60. [DOI: 10.1016/j.soc.2004.06.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
300 Volz AC, Omengo B, Gehrke S, Kluger PJ. Comparing the use of differentiated adipose-derived stem cells and mature adipocytes to model adipose tissue in vitro. Differentiation 2019;110:19-28. [PMID: 31568881 DOI: 10.1016/j.diff.2019.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
301 Yin Y, He X, Wang J, Wu R, Xu X, Hong Y, Tian B, Chen F. Pore size-mediated macrophage M1-to-M2 transition influences new vessel formation within the compartment of a scaffold. Applied Materials Today 2020;18:100466. [DOI: 10.1016/j.apmt.2019.100466] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
302 Wei K, Kuhnert F, Kuo CJ. Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways. J Mol Med 2008;86:161-9. [DOI: 10.1007/s00109-007-0261-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
303 Wei X, Liu H, Li X, Liu X. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4. Ann Hepatol 2019;18:869-78. [PMID: 31477445 DOI: 10.1016/j.aohep.2019.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
304 Marston KJ, Brown BM, Rainey-smith SR, Peiffer JJ. Resistance Exercise-Induced Responses in Physiological Factors Linked with Cognitive Health. JAD 2019;68:39-64. [DOI: 10.3233/jad-181079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
305 Feng L, Ju M, Lee KYV, Mackey A, Evangelista M, Iwata D, Adamson P, Lashkari K, Foxton R, Shima D, Ng YS. A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration. Am J Pathol 2017;187:2208-21. [PMID: 28739342 DOI: 10.1016/j.ajpath.2017.06.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
306 Liang Y, Zhang Y, Wang G, Li Y, Huang W. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway. Molecules 2017;22:E126. [PMID: 28098802 DOI: 10.3390/molecules22010126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
307 Truong TH, Carroll KS. Redox regulation of protein kinases. Crit Rev Biochem Mol Biol 2013;48:332-56. [PMID: 23639002 DOI: 10.3109/10409238.2013.790873] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 10.8] [Reference Citation Analysis]
308 Crawshaw A, Griffiths C, Young H. Investigational VEGF antagonists for psoriasis. Expert Opinion on Investigational Drugs 2011;21:33-43. [DOI: 10.1517/13543784.2012.636351] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
309 Cho SJ, George CL, Snyder JM, Acarregui MJ. Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor. Am J Respir Cell Mol Biol 2005;33:622-8. [PMID: 16141447 DOI: 10.1165/rcmb.2005-0050OC] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
310 Vieira VJ, dʼAcampora AJ, Marcos ABW, Di Giunta G, de Vasconcellos ZAA, Bins-ely J, dʼEça Neves R, Figueiredo CP. Vascular Endothelial Growth Factor Overexpression Positively Modulates the Characteristics of Periprosthetic Tissue of Polyurethane-Coated Silicone Breast Implant in Rats: . Plastic and Reconstructive Surgery 2010;126:1899-910. [DOI: 10.1097/prs.0b013e3181f446d5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
311 Wang S, Chen M, Zhang X, Zhang L, Jia M, Shen Z, Wang J, Zhao B, Gong Y, Gong J. Aneurysm and Artery Dissection Following the Use of Vascular Endothelial Growth Factor Inhibitor: A Real-World Analysis Using a Spontaneous Reporting System. J Am Heart Assoc 2021;10:e020844. [PMID: 34845918 DOI: 10.1161/JAHA.121.020844] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Favier J, Gimenez-Roqueplo AP. Pheochromocytomas: the (pseudo)-hypoxia hypothesis. Best Pract Res Clin Endocrinol Metab 2010;24:957-68. [PMID: 21115164 DOI: 10.1016/j.beem.2010.10.004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
313 El-Adl K, Sakr H, Nasser M, Alswah M, Shoman FMA. 5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations. Arch Pharm (Weinheim) 2020;353:e2000079. [PMID: 32515896 DOI: 10.1002/ardp.202000079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
314 Peng Y, Wang L, Du C, Gu J. Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy. Int J Colorectal Dis. 2012;27:1555-1560. [PMID: 22645074 DOI: 10.1007/s00384-012-1485-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
315 Manni L, Antonelli A, Costa N, Aloe L. Stress alters vascular?endothelial growth factor expression in rat arteries: Role of nerve growth factor. Basic Res Cardiol. [DOI: 10.1007/s00395-004-502-7] [Reference Citation Analysis]
316 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2006; 14(16): 1621-1626 [DOI: 10.11569/wcjd.v14.i16.1621] [Reference Citation Analysis]
317 Koepsel JT, Nguyen EH, Murphy WL. Differential effects of a soluble or immobilized VEGFR-binding peptide. Integr Biol (Camb) 2012;4:914-24. [PMID: 22733256 DOI: 10.1039/c2ib20055d] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
318 Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol 2007;91:226-9. [PMID: 17244661 DOI: 10.1136/bjo.2006.101121] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
319 Pan J, Heiser A, Marget M, Steinmann J, Kabelitz D. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination. Gene Ther 2005;12:742-50. [DOI: 10.1038/sj.gt.3302470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
320 Wang H, Liu Y, Chai L, Wang H. Effects of nitrite exposure on metamorphosis and skeletal development of Bufo gargarizans. Environ Sci Pollut Res. [DOI: 10.1007/s11356-022-19468-5] [Reference Citation Analysis]
321 Motzer RJ, Hoosen S, Bello CL, Christensen JG. Sunitinib malate for the treatment of solid tumours: a review of current clinical data. Expert Opinion on Investigational Drugs 2006;15:553-61. [DOI: 10.1517/13543784.15.5.553] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
322 Zarbin M, Szirth B. Current Treatment of Age-Related Macular Degeneration. Optometry and Vision Science 2007;84:E559-72. [DOI: 10.1097/opx.0b013e3180de4dd7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
323 Hu W, Chan GK, Lou J, Wu Q, Wang H, Duan R, Cheng MY, Dong TT, Tsim KW. The extract of Polygoni Cuspidati Rhizoma et Radix suppresses the vascular endothelial growth factor-induced angiogenesis. Phytomedicine 2018;42:135-43. [DOI: 10.1016/j.phymed.2018.03.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
324 Clarkin CE, Gerstenfeld LC. VEGF and bone cell signalling: an essential vessel for communication? Cell Biochem Funct 2013;31:1-11. [PMID: 23129289 DOI: 10.1002/cbf.2911] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 7.3] [Reference Citation Analysis]
325 Koumoutsakos P, Bayati B, Milde F, Tauriello G. PARTICLE SIMULATIONS OF MORPHOGENESIS. Math Models Methods Appl Sci 2011;21:955-1006. [DOI: 10.1142/s021820251100543x] [Cited by in Crossref: 14] [Article Influence: 1.3] [Reference Citation Analysis]
326 Reinmuth N, Bryl M, Bondarenko I, Syrigos K, Vladimirov V, Zereu M, Bair AH, Hilton F, Liau K, Kasahara K. PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study. BioDrugs 2019;33:555-70. [PMID: 31338773 DOI: 10.1007/s40259-019-00363-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
327 Avisar I, Weinberger D, Kremer I. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model. Curr Eye Res 2010;35:108-15. [PMID: 20136420 DOI: 10.3109/02713680903429007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
328 Brioschi AM, Calderoni S, Zara GP, Priano L, Gasco MR, Mauro A. Solid lipid nanoparticles for brain tumors therapy. Nanoneuroscience and Nanoneuropharmacology. Elsevier; 2009. pp. 193-223. [DOI: 10.1016/s0079-6123(08)80011-8] [Cited by in Crossref: 9] [Article Influence: 0.7] [Reference Citation Analysis]
329 Tsao AS, Lin H, Carter BW, Lee JJ, Rice D, Vaporcyan A, Swisher S, Mehran R, Heymach J, Nilsson M, Fan Y, Nunez M, Diao L, Wang J, Fujimoto J, Wistuba II, Hong WK. Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma. J Thorac Oncol 2018;13:246-57. [PMID: 29313814 DOI: 10.1016/j.jtho.2017.10.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
330 Baffert F, Thurston G, Rochon-duck M, Le T, Brekken R, Mcdonald DM. Age-Related Changes in Vascular Endothelial Growth Factor Dependency and Angiopoietin-1-Induced Plasticity of Adult Blood Vessels. Circulation Research 2004;94:984-92. [DOI: 10.1161/01.res.0000125295.43813.1f] [Cited by in Crossref: 77] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
331 Crociani O, Zanieri F, Pillozzi S, Lastraioli E, Stefanini M, Fiore A, Fortunato A, D'Amico M, Masselli M, De Lorenzo E, Gasparoli L, Chiu M, Bussolati O, Becchetti A, Arcangeli A. hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer. Sci Rep. 2013;3:3308. [PMID: 24270902 DOI: 10.1038/srep03308] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
332 Wolf G, Abolmaali N. Preclinical molecular imaging using PET and MRI. Recent Results Cancer Res. 2013;187:257-310. [PMID: 23179885 DOI: 10.1007/978-3-642-10853-2_9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
333 Chen W, Tang T, Eastham-Anderson J, Dunlap D, Alicke B, Nannini M, Gould S, Yauch R, Modrusan Z, DuPree KJ, Darbonne WC, Plowman G, de Sauvage FJ, Callahan CA. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci U S A 2011;108:9589-94. [PMID: 21597001 DOI: 10.1073/pnas.1017945108] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 7.5] [Reference Citation Analysis]
334 Zhang J, Peng B. NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro. Cell Prolif 2009;42:150-61. [PMID: 19317804 DOI: 10.1111/j.1365-2184.2009.00588.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
335 Albrecht ED, Pepe GJ. Regulation of Uterine Spiral Artery Remodeling: a Review. Reprod Sci 2020;27:1932-42. [PMID: 32548805 DOI: 10.1007/s43032-020-00212-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
336 Ucar B, Yusufogullari S, Humpel C. Collagen hydrogels loaded with fibroblast growth factor-2 as a bridge to repair brain vessels in organotypic brain slices. Exp Brain Res 2020;238:2521-9. [PMID: 32862235 DOI: 10.1007/s00221-020-05907-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
337 Liew SC, Das-Gupta E, Chakravarthi S, Wong SF, Lee N, Safdar N, Jamil A. Differential expression of the angiogenesis growth factors in psoriasis vulgaris. BMC Res Notes 2012;5:201. [PMID: 22537619 DOI: 10.1186/1756-0500-5-201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
338 Morooka S, Hoshina M, Kii I, Okabe T, Kojima H, Inoue N, Okuno Y, Denawa M, Yoshida S, Fukuhara J, Ninomiya K, Ikura T, Furuya T, Nagano T, Noda K, Ishida S, Hosoya T, Ito N, Yoshimura N, Hagiwara M. Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice. Mol Pharmacol 2015;88:316-25. [PMID: 25993998 DOI: 10.1124/mol.114.097345] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
339 Cho H, Jo Y, Choung S. Protective Effects of Spirulina maxima against Blue Light-Induced Retinal Damages in A2E-Laden ARPE-19 Cells and Balb/c Mice. Nutrients 2022;14:401. [DOI: 10.3390/nu14030401] [Reference Citation Analysis]
340 Arcondéguy T, Lacazette E, Millevoi S, Prats H, Touriol C. VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Res 2013;41:7997-8010. [PMID: 23851566 DOI: 10.1093/nar/gkt539] [Cited by in Crossref: 141] [Cited by in F6Publishing: 134] [Article Influence: 15.7] [Reference Citation Analysis]
341 Ennen JP, Verma M, Asakura A. Vascular-targeted therapies for Duchenne muscular dystrophy. Skelet Muscle 2013;3:9. [PMID: 23618411 DOI: 10.1186/2044-5040-3-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
342 Yamaya S, Ozawa H, Kanno H, Kishimoto KN, Sekiguchi A, Tateda S, Yahata K, Ito K, Shimokawa H, Itoi E. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury: Laboratory investigation. JNS 2014;121:1514-25. [DOI: 10.3171/2014.8.jns132562] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
343 Yuan J, Handy RD, Moody AJ, Bryson P. Response of blood vessels in vitro to hyperbaric oxygen (HBO): modulation of VEGF and NO(x) release by external lactate or arginine. Biochim Biophys Acta 2009;1787:828-34. [PMID: 19298791 DOI: 10.1016/j.bbabio.2009.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
344 Ventrice P, Leporini C, Aloe JF, Greco E, Leuzzi G, Marrazzo G, Scorcia GB, Bruzzichesi D, Nicola V, Scorcia V. Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases. J Pharmacol Pharmacother 2013;4:S38-42. [PMID: 24347979 DOI: 10.4103/0976-500X.120947] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
345 Rashidi B, Malekzadeh M. Evaluation of Endometrial Angiogenesis in Mice Uterus Before Implantation in Natural Cycles Followed by Use of Human Menopausal Gonadotropin - Human Chorionic Gonadotropin Drugs and Epigallocatechin Gallate. Adv Biomed Res 2017;6:138. [PMID: 29279836 DOI: 10.4103/2277-9175.218029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
346 Everett WH, Curiel DT. Gene therapy for radioprotection. Cancer Gene Ther 2015;22:172-80. [PMID: 25721205 DOI: 10.1038/cgt.2015.8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
347 Han KY, Fahd DC, Tshionyi M, Allemann N, Jain S, Chang JH, Azar DT. MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett 2012;19:1334-9. [PMID: 22670674 DOI: 10.2174/092986612803521639] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
348 Joshi A, Xu Z, Ikegami Y, Yoshida K, Sakai Y, Joshi A, Kaur T, Nakao Y, Yamashita Y, Baba H, Aishima S, Singh N, Ijima H. Exploiting synergistic effect of externally loaded bFGF and endogenous growth factors for accelerated wound healing using heparin functionalized PCL/gelatin co-spun nanofibrous patches. Chemical Engineering Journal 2021;404:126518. [DOI: 10.1016/j.cej.2020.126518] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
349 Erkenbrack EM, Petsios E. A Conserved Role for VEGF Signaling in Specification of Homologous Mesenchymal Cell Types Positioned at Spatially Distinct Developmental Addresses in Early Development of Sea Urchins. J Exp Zool B Mol Dev Evol 2017;328:423-32. [PMID: 28544452 DOI: 10.1002/jez.b.22743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
350 Seiffge DJ, Lapina NE, Tsagogiorgas C, Theisinger B, Henning RH, Schilling L. Improvement of oxygen supply by an artificial carrier in combination with normobaric oxygenation decreases the volume of tissue hypoxia and tissue damage from transient focal cerebral ischemia. Exp Neurol 2012;237:18-25. [PMID: 22728375 DOI: 10.1016/j.expneurol.2012.06.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
351 Brys I, Bobela W, Schneider BL, Aebischer P, Fuentes R. Spinal cord stimulation improves forelimb use in an alpha-synuclein animal model of Parkinson's disease. Int J Neurosci 2017;127:28-36. [PMID: 26856727 DOI: 10.3109/00207454.2016.1138296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
352 Bequet-romero M, Ayala M, Acevedo BE, Rodríguez EG, López Ocejo O, Torrens I, Gavilondo JV. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice. Angiogenesis 2007;10:23-34. [DOI: 10.1007/s10456-006-9062-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
353 Li J, Cao F, Wu B, Yang J, Xu W, Wang W, Wei X, Liu G, Zhao D. Immobilization of bioactive vascular endothelial growth factor onto Ca-deficient hydroxyapatite-coated Mg by covalent bonding using polydopamine. J Orthop Translat 2021;30:82-92. [PMID: 34660198 DOI: 10.1016/j.jot.2021.06.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Liu Y, Zhao L, Li D, Yin Y, Zhang CY, Li J, Zhang Y. Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development. Protein Cell 2013;4:932-41. [PMID: 24203759 DOI: 10.1007/s13238-013-3092-z] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
355 Galvagni F, Pennacchini S, Salameh A, Rocchigiani M, Neri F, Orlandini M, Petraglia F, Gotta S, Sardone GL, Matteucci G, Terstappen GC, Oliviero S. Endothelial Cell Adhesion to the Extracellular Matrix Induces c-Src–Dependent VEGFR-3 Phosphorylation Without the Activation of the Receptor Intrinsic Kinase Activity. Circulation Research 2010;106:1839-48. [DOI: 10.1161/circresaha.109.206326] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
356 Giovannini M, Aldrighetti D, Zucchinelli P, Belli C, Villa E. Antiangiogenic strategies in breast cancer management. Crit Rev Oncol Hematol 2010;76:13-35. [PMID: 20702105 DOI: 10.1016/j.critrevonc.2009.12.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
357 Takahashi T, Fujimura M, Koyama M, Kanazawa M, Usuki F, Nishizawa M, Shimohata T. Methylmercury Causes Blood-Brain Barrier Damage in Rats via Upregulation of Vascular Endothelial Growth Factor Expression. PLoS One 2017;12:e0170623. [PMID: 28118383 DOI: 10.1371/journal.pone.0170623] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
358 Girotti A, Escalera-Anzola S, Alonso-Sampedro I, González-Valdivieso J, Arias FJ. Aptamer-Functionalized Natural Protein-Based Polymers as Innovative Biomaterials. Pharmaceutics 2020;12:E1115. [PMID: 33228250 DOI: 10.3390/pharmaceutics12111115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
359 Shintani Y, Takashima S, Asano Y, Kato H, Liao Y, Yamazaki S, Tsukamoto O, Seguchi O, Yamamoto H, Fukushima T, Sugahara K, Kitakaze M, Hori M. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J 2006;25:3045-55. [PMID: 16763549 DOI: 10.1038/sj.emboj.7601188] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 7.2] [Reference Citation Analysis]
360 Takahashi H, Tamaki Y, Ishii N, Oikawa N, Mizuguchi E, Francis JH, Inoue Y, Iriyama A, Obata R, Yanagi Y. Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo. Curr Eye Res 2008;33:1002-10. [PMID: 19085383 DOI: 10.1080/02713680802492440] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
361 Lacal PM, Graziani G. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors. Pharmacol Res 2018;136:97-107. [PMID: 30170190 DOI: 10.1016/j.phrs.2018.08.023] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
362 Hazem RM, Mohamed AA, Ghareb N, Mehanna ET, Mesbah NM, Abo-Elmatty DM, Elgawish MS. Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma. Eur J Pharmacol 2021;892:173747. [PMID: 33232730 DOI: 10.1016/j.ejphar.2020.173747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
363 Siegle JM, Basin A, Sastre-Perona A, Yonekubo Y, Brown J, Sennett R, Rendl M, Tsirigos A, Carucci JA, Schober M. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma. Nat Commun 2014;5:4511. [PMID: 25077433 DOI: 10.1038/ncomms5511] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 9.8] [Reference Citation Analysis]
364 Lu J, Zhang K, Chen S, Wen W. Grape seed extract inhibits VEGF expression via reducing HIF-1alpha protein expression. Carcinogenesis 2009;30:636-44. [PMID: 19131542 DOI: 10.1093/carcin/bgp009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
365 Schuster C, Akslen LA, Stokowy T, Straume O. Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. J Pathol Clin Res 2019;5:53-62. [PMID: 30225999 DOI: 10.1002/cjp2.116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
366 García Fernández R, Sánchez Pérez M, Sánchez Maldonado B, García-palencia P, Naranjo Freixa C, Palomo Yagüe A, Flores J. Iberian pig early pregnancy: Vascular endothelial growth factor receptor system expression in the maternofetal interface in healthy and arresting conceptuses. Theriogenology 2015;83:334-43. [DOI: 10.1016/j.theriogenology.2014.07.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
367 Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 2008;75:131-7. [DOI: 10.1016/j.jbspin.2007.09.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
368 Liu W, Dai J, Xue W. Design and self-assembly of albumin nanoclusters as a dynamic-covalent targeting co-delivery and stimuli-responsive controlled release platform. J Mater Chem B 2018;6:6817-30. [PMID: 32254698 DOI: 10.1039/c8tb01791c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
369 Choi HS, Kim MK, Lee K, Lee KM, Choi YK, Shin YC, Cho SG, Ko SG. SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2. Oncotarget 2016;7:32969-79. [PMID: 27105528 DOI: 10.18632/oncotarget.8808] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
370 Cai Z, Dong L, Song C, Zhang Y, Zhu C, Zhang Y, Ling Q, Hoffmann PR, Li J, Huang Z, Li W. Methylseleninic Acid Provided at Nutritional Selenium Levels Inhibits Angiogenesis by Down-regulating Integrin β3 Signaling. Sci Rep 2017;7:9445. [PMID: 28842587 DOI: 10.1038/s41598-017-09568-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
371 Shibata Y, Kikuchi R, Ishii H, Suzuki S, Harada K, Hirayama K, Suzuki A, Tatami Y, Kondo K, Murohara T. Balance between angiogenic and anti-angiogenic isoforms of VEGF-A is associated with the complexity and severity of coronary artery disease. Clin Chim Acta 2018;478:114-9. [PMID: 29289620 DOI: 10.1016/j.cca.2017.12.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
372 Wong ML, Prawira A, Kaye AH, Hovens CM. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas. J Clin Neurosci 2009;16:1119-30. [PMID: 19556134 DOI: 10.1016/j.jocn.2009.02.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
373 Kao HH, Kuo CY, Chen KS, Chen JP. Preparation of Gelatin and Gelatin/Hyaluronic Acid Cryogel Scaffolds for the 3D Culture of Mesothelial Cells and Mesothelium Tissue Regeneration. Int J Mol Sci 2019;20:E4527. [PMID: 31547444 DOI: 10.3390/ijms20184527] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
374 Baniebrahimi G, Khanmohammadi R, Mir F. Teeth-derived stem cells: A source for cell therapy. J Cell Physiol 2019;234:2426-35. [PMID: 30238990 DOI: 10.1002/jcp.27270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
375 Kodama Y, Kitta Y, Nakamura T, Takano H, Umetani K, Fujioka D, Saito Y, Kawabata K, Obata J, Mende A, Kobayashi T, Kugiyama K. Atorvastatin Increases Plasma Soluble Fms-Like Tyrosine Kinase-1 and Decreases Vascular Endothelial Growth Factor and Placental Growth Factor in Association With Improvement of Ventricular Function in Acute Myocardial Infarction. Journal of the American College of Cardiology 2006;48:43-50. [DOI: 10.1016/j.jacc.2006.03.035] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
376 Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, Jiang S, Gilliland DG, Chin L, Wong WH, Castrillon DH, DePinho RA. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;128:309-323. [PMID: 17254969 DOI: 10.1016/j.cell.2006.12.029] [Cited by in Crossref: 739] [Cited by in F6Publishing: 732] [Article Influence: 49.3] [Reference Citation Analysis]
377 Li S, Chen X, Wu T, Zhang M, Zhang X, Ji Z. Role of heparin on serum VEGF levels and local VEGF contents in reducing the severity of experimental severe acute pancreatitis in rats. Scandinavian Journal of Gastroenterology 2012;47:237-44. [DOI: 10.3109/00365521.2011.647063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
378 Amburgey OA, Chapman AC, May V, Bernstein IM, Cipolla MJ. Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling. Hypertension 2010;56:1003-8. [PMID: 20855653 DOI: 10.1161/HYPERTENSIONAHA.110.158931] [Cited by in Crossref: 72] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
379 Sunderland KS, Yang M, Mao C. Nanomedizin auf Phagenbasis: von Sonden zu Therapeutika für eine Präzisionsmedizin. Angew Chem 2017;129:1992-2022. [DOI: 10.1002/ange.201606181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
380 Savitskaya TV, Kisialeu LP, Lipay NV. The mRNA expression of various angiogenesis-related genes in pediatric sarcomas and nonmalignant lesions of tissue. Pediatr Hematol Oncol 2012;29:28-37. [PMID: 22304008 DOI: 10.3109/08880018.2011.628366] [Reference Citation Analysis]
381 Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li J, Harris AL. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research 2008;75:144-54. [DOI: 10.1016/j.mvr.2007.06.006] [Cited by in Crossref: 142] [Cited by in F6Publishing: 140] [Article Influence: 10.1] [Reference Citation Analysis]
382 Becker M, Tilki D, Szarvas T, Rübben H, Ergün S. Urinbasierte Angiogenesemarker beim Urothelkarzinom der Harnblase. Urologe 2009;48:609-14. [DOI: 10.1007/s00120-009-1989-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
383 Yin Q, Ma J, Han X, Zhang H, Wang F, Zhuang P, Zhang Y. Spatiotemporal variations of vascular endothelial growth factor in the brain of diabetic cognitive impairment. Pharmacol Res 2021;163:105234. [PMID: 33053446 DOI: 10.1016/j.phrs.2020.105234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
384 Mulcahy MF, Benson AB. Bevacizumab in the treatment of colorectal cancer. Expert Opin Biol Ther. 2005;5:997-1005. [PMID: 16018743 DOI: 10.1517/14712598.5.7.997] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
385 Carbajo-Pescador S, Ordoñez R, Benet M, Jover R, García-Palomo A, Mauriz JL, González-Gallego J. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer. 2013;109:83-91. [PMID: 23756865 DOI: 10.1038/bjc.2013.285] [Cited by in Crossref: 140] [Cited by in F6Publishing: 136] [Article Influence: 15.6] [Reference Citation Analysis]
386 Nguyen TT, Guymer R. Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration. Expert Rev Clin Pharmacol 2015;8:541-8. [PMID: 26289225 DOI: 10.1586/17512433.2015.1075879] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
387 Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F. Gorham-Stout Syndrome: A Monocyte-Mediated Cytokine Propelled Disease. J Bone Miner Res 2006;21:207-18. [DOI: 10.1359/jbmr.051019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
388 Yoshizaki T, Motomura W, Tanno S, Kumei S, Yoshizaki Y, Tanno S, Okumura T. Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells. J Exp Clin Cancer Res 2010;29:22. [PMID: 20214829 DOI: 10.1186/1756-9966-29-22] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
389 Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogenesis: FXIII and angiogenesis. Journal of Thrombosis and Haemostasis 2006;4:19-25. [DOI: 10.1111/j.1538-7836.2005.01473.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 4.2] [Reference Citation Analysis]
390 Shido K, Chavez D, Cao Z, Ko J, Rafii S, Ding BS. Platelets prime hematopoietic and vascular niche to drive angiocrine-mediated liver regeneration. Signal Transduct Target Ther 2017;2:16044. [PMID: 29201496 DOI: 10.1038/sigtrans.2016.44] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
391 Ehashi T, Koyama T, Ookawa K, Ohshima N, Miyoshi H. Effects of oncostatin M on secretion of vascular endothelial growth factor and reconstruction of liver-like structure by fetal liver cells in monolayer and three-dimensional cultures. J Biomed Mater Res A 2007;82:73-9. [PMID: 17269136 DOI: 10.1002/jbm.a.31027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
392 Itatani Y, Kawada K, Yamamoto T, Sakai Y. Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway. Int J Mol Sci 2018;19:E1232. [PMID: 29670046 DOI: 10.3390/ijms19041232] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
393 Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9-23. [PMID: 18175241 DOI: 10.1080/14767050701830480] [Cited by in Crossref: 445] [Cited by in F6Publishing: 414] [Article Influence: 31.8] [Reference Citation Analysis]
394 Färkkilä A, Haltia UM, Tapper J, McConechy MK, Huntsman DG, Heikinheimo M. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary. Ann Med 2017;49:435-47. [PMID: 28276867 DOI: 10.1080/07853890.2017.1294760] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
395 Xia L, Wang H, Munk S, Frecker H, Goldberg HJ, Fantus IG, Whiteside CI. Reactive oxygen species, PKC-beta1, and PKC-zeta mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells. Am J Physiol Endocrinol Metab 2007;293:E1280-8. [PMID: 17711990 DOI: 10.1152/ajpendo.00223.2007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
396 Yamakawa D, Kidoya H, Sakimoto S, Jia W, Takakura N. 2-Methoxycinnamaldehyde inhibits tumor angiogenesis by suppressing Tie2 activation. Biochemical and Biophysical Research Communications 2011;415:174-80. [DOI: 10.1016/j.bbrc.2011.10.053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
397 Jain HV, Jackson TL. A hybrid model of the role of VEGF binding in endothelial cell migration and capillary formation. Front Oncol 2013;3:102. [PMID: 23675570 DOI: 10.3389/fonc.2013.00102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
398 Morioka M, Kawakubo-yasukochi T, Hayashi Y, Hazekawa M, Nishinakagawa T, Ono K, Kawano S, Nakamura S, Nakashima M. Exosomes from oral squamous carcinoma cell lines, SQUU-A and SQUU-B, define the tropism of lymphatic dissemination. Journal of Oral Biosciences 2016;58:180-4. [DOI: 10.1016/j.job.2016.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
399 Li J, Liu X, Zang S, Zhou J, Zhang F, Sun B, Qi D, Li X, Kong J, Jin D, Yang X, Luo Y, Lu Y, Lin B, Niu W, Liu T. Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner. Cancer Lett 2020;492:71-83. [PMID: 32860852 DOI: 10.1016/j.canlet.2020.08.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
400 Ouyang W, Li J, Shi X, Costa M, Huang C. Essential role of PI-3K, ERKs and calcium signal pathways in nickel-induced VEGF expression. Mol Cell Biochem 2005;279:35-43. [DOI: 10.1007/s11010-005-8214-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
401 Wang QH, Wang YJ, Gao YT, Du Z, Yang B, Zhang Y, Guo H, Jing L, Yu J, Xu YJ. Significance of expression of vascular endothelial growth factor B and its splice isoforms in different types of liver lesions. Shijie Huaren Xiaohua Zazhi 2011; 19(1): 31-37 [DOI: 10.11569/wcjd.v19.i1.31] [Reference Citation Analysis]
402 Gu F, Neufeld R, Amsden B. Sustained release of bioactive therapeutic proteins from a biodegradable elastomeric device. J Control Release 2007;117:80-9. [PMID: 17126945 DOI: 10.1016/j.jconrel.2006.09.077] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
403 Halper J. Growth factors as active participants in carcinogenesis: a perspective. Vet Pathol 2010;47:77-97. [PMID: 20080487 DOI: 10.1177/0300985809352981] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
404 Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl 2021;130:112466. [PMID: 34702541 DOI: 10.1016/j.msec.2021.112466] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
405 Mohamed HE, El-Swefy SE, Mohamed RH, Ghanim AM. Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats. Exp Toxicol Pathol 2013;65:197-203. [PMID: 21920723 DOI: 10.1016/j.etp.2011.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
406 Bdolah Y, Sukhatme VP, Karumanchi SA. Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights. Seminars in Nephrology 2004;24:548-56. [DOI: 10.1016/j.semnephrol.2004.07.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
407 Kim HJ, Oh SC. Novel Systemic Therapies for Advanced Gastric Cancer. J Gastric Cancer 2018;18:1-19. [PMID: 29629216 DOI: 10.5230/jgc.2018.18.e3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
408 O'Rafferty C, O'Regan GM, Irvine AD, Smith OP. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol 2015;171:38-51. [PMID: 26123689 DOI: 10.1111/bjh.13557] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
409 Xing H, Yang X, Xu Y, Tang K, Tian Z, Chen Z, Zhang Y, Xue Z, Rao Q, Wang M, Wang J. Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells. Cytotherapy 2021;23:810-9. [PMID: 34244079 DOI: 10.1016/j.jcyt.2021.05.008] [Reference Citation Analysis]
410 Banadakoppa M, Balakrishnan M, Yallampalli C. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells. Am J Reprod Immunol 2018;80:e13033. [PMID: 30099798 DOI: 10.1111/aji.13033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
411 Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF Gene Polymorphisms are Associated with Risk of Tetralogy of Fallot. Med Sci Monit 2015;21:3474-82. [PMID: 26558525 DOI: 10.12659/msm.894568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
412 Ma J, Lai G, Lu Z. Effect of 410 nm photodynamic therapy with hemoporfin on the expression of vascular endothelial growth factor (VEGF) in cultured human vascular endothelial cells. Lasers Med Sci 2019;34:149-55. [DOI: 10.1007/s10103-018-2649-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
413 Gaspar D, Peixoto R, De Pieri A, Striegl B, Zeugolis DI, Raghunath M. Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs. Advanced Drug Delivery Reviews 2019;146:126-54. [DOI: 10.1016/j.addr.2019.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
414 Bahrami B, Zhu M, Hong T, Chang A. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance. Diabetologia 2016;59:1594-608. [PMID: 27179659 DOI: 10.1007/s00125-016-3974-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
415 Ulyatt C, Walker J, Ponnambalam S. Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells. Biochem Biophys Res Commun 2011;404:774-9. [PMID: 21168388 DOI: 10.1016/j.bbrc.2010.12.057] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
416 Glubb DM, Cerri E, Giese A, Zhang W, Mirza O, Thompson EE, Chen P, Das S, Jassem J, Rzyman W, Lingen MW, Salgia R, Hirsch FR, Dziadziuszko R, Ballmer-Hofer K, Innocenti F. Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clin Cancer Res 2011;17:5257-67. [PMID: 21712447 DOI: 10.1158/1078-0432.CCR-11-0379] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
417 Hubschman JP, Reddy S, Schwartz SD. Age-related macular degeneration: current treatments. Clin Ophthalmol 2009;3:155-66. [PMID: 19668560 DOI: 10.2147/opth.s2094] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
418 Halimi J, Azizi M, Bobrie G, Bouché O, Deray G, des Guetz G, Lecomte T, Levy B, Mourad J, Nochy D, Oudard S, Rieu P, Sahali D. Effets vasculaires et rénaux des médicaments anti-angiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD). Néphrologie & Thérapeutique 2008;4:602-15. [DOI: 10.1016/j.nephro.2008.10.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
419 Liu C, Lei T, Ino K, Matsue T, Tao N, Li CZ. Real-time monitoring biomarker expression of carcinoma cells by surface plasmon resonance biosensors. Chem Commun (Camb) 2012;48:10389-91. [PMID: 22957340 DOI: 10.1039/c2cc34853e] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
420 Shang R, Lal N, Puri K, Hussein B, Rodrigues B. Involvement of Heparanase in Endothelial Cell-Cardiomyocyte Crosstalk. Adv Exp Med Biol 2020;1221:721-45. [PMID: 32274734 DOI: 10.1007/978-3-030-34521-1_30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
421 Hao S, Gao J, Wang H, Zhang Y, Pavlov A, Ge H, Yang Z. AG-1031 and AG-1503 improve cognitive deficits by promoting apoptosis and inhibiting autophagy in C6 glioma model rats. Brain Res 2018;1699:1-8. [PMID: 29935156 DOI: 10.1016/j.brainres.2018.06.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
422 Pang JH, Farhatnia Y, Godarzi F, Tan A, Rajadas J, Cousins BG, Seifalian AM. In situ Endothelialization: Bioengineering Considerations to Translation. Small 2015;11:6248-64. [DOI: 10.1002/smll.201402579] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
423 Page AV, Liles WC. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013;4:507-516. [PMID: 23669075 DOI: 10.4161/viru.24530] [Cited by in Crossref: 139] [Cited by in F6Publishing: 138] [Article Influence: 15.4] [Reference Citation Analysis]
424 Jia W, Burns JM, Villantay B, Tang JC, Vankayala R, Lertsakdadet B, Choi B, Nelson JS, Anvari B. Intravital Vascular Phototheranostics and Real-Time Circulation Dynamics of Micro- and Nanosized Erythrocyte-Derived Carriers. ACS Appl Mater Interfaces 2020;12:275-87. [PMID: 31820920 DOI: 10.1021/acsami.9b18624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
425 Yang X, Zhang Y, Yang Y, Lim S, Cao Z, Rak J, Cao Y. Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth. Proc Natl Acad Sci U S A 2013;110:13932-7. [PMID: 23918367 DOI: 10.1073/pnas.1309629110] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
426 Infanger M, Kossmehl P, Shakibaei M, Baatout S, Witzing A, Grosse J, Bauer J, Cogoli A, Faramarzi S, Derradji H. Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: impact of vascular endothelial growth factor. Apoptosis. 2006;11:749-764. [PMID: 16528471 DOI: 10.1007/s10495-006-5697-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 83] [Article Influence: 6.1] [Reference Citation Analysis]
427 Spitzer MS, Ziemssen F, Bartz-Schmidt KU, Gelisken F, Szurman P. Treatment of age-related macular degeneration: focus on ranibizumab. Clin Ophthalmol 2008;2:1-14. [PMID: 19668384 DOI: 10.2147/opth.s1959] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
428 Qi DD, Ding MY, Wang T, Hayat MA, Liu T, Zhang JT. The Therapeutic Effects of Oral Intake of Hydrogen Rich Water on Cutaneous Wound Healing in Dogs. Vet Sci 2021;8:264. [PMID: 34822637 DOI: 10.3390/vetsci8110264] [Reference Citation Analysis]
429 Sentilhes L, Michel C, Lecourtois M, Catteau J, Bourgeois P, Laudenbach V, Marret S, Laquerrière A. Vascular endothelial growth factor and its high-affinity receptor (VEGFR-2) are highly expressed in the human forebrain and cerebellum during development. J Neuropathol Exp Neurol 2010;69:111-28. [PMID: 20084021 DOI: 10.1097/NEN.0b013e3181ccc9a9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
430 Ewan LC, Jopling HM, Jia H, Mittar S, Bagherzadeh A, Howell GJ, Walker JH, Zachary IC, Ponnambalam S. Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic 2006;7:1270-82. [PMID: 17004325 DOI: 10.1111/j.1600-0854.2006.00462.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 9.0] [Reference Citation Analysis]
431 Fritsch H, Hoermann R, Bitsche M, Pechriggl E, Reich O. Development of epithelial and mesenchymal regionalization of the human fetal utero-vaginal anlagen. J Anat 2013;222:462-72. [PMID: 23406280 DOI: 10.1111/joa.12029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
432 Liu Y, Lan W, Wang C, Cao C. A putative G-quadruplex structure in the proximal promoter of VEGFR-2 has implications for drug design to inhibit tumor angiogenesis. J Biol Chem 2018;293:8947-55. [PMID: 29666187 DOI: 10.1074/jbc.RA118.002666] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
433 Choi SH, Chung M, Park SW, Jeon NL, Kim JH, Yu YS. Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis. Korean J Ophthalmol 2018;32:70-6. [PMID: 29376221 DOI: 10.3341/kjo.2016.0115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
434 Dasgupta P. Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis. Pharmacol Ther. 2004;102:61-85. [PMID: 15056499 DOI: 10.1016/j.pharmthera.2004.02.002] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 6.1] [Reference Citation Analysis]
435 Kaza E, Ablasser K, Poutias D, Griffiths ER, Saad FA, Hofstaetter JG, del Nido PJ, Friehs I. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. Cardiovasc Res 2011;89:410-8. [PMID: 20935166 DOI: 10.1093/cvr/cvq321] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
436 Guan F, Villegas G, Teichman J, Mundel P, Tufro A. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am J Physiol Renal Physiol 2006;291:F422-8. [PMID: 16597608 DOI: 10.1152/ajprenal.00448.2005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 4.9] [Reference Citation Analysis]
437 Ma J, Hu W, Zhang P, Sun Y, Wang N, Teng X, Qiao Q. The Association Between VEGF +936C/T and -634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects. Cancer Invest 2015;33:312-7. [PMID: 26067906 DOI: 10.3109/07357907.2015.1044664] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
438 Rabinovsky ED. The multifunctional role of IGF-1 in peripheral nerve regeneration. Neurological Research 2013;26:204-10. [DOI: 10.1179/016164104225013851] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
439 Iaquinta MR, Mazzoni E, Manfrini M, D'Agostino A, Trevisiol L, Nocini R, Trombelli L, Barbanti-Brodano G, Martini F, Tognon M. Innovative Biomaterials for Bone Regrowth. Int J Mol Sci 2019;20:E618. [PMID: 30709008 DOI: 10.3390/ijms20030618] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
440 Saw PE, Song EW. Phage display screening of therapeutic peptide for cancer targeting and therapy. Protein Cell 2019;10:787-807. [PMID: 31140150 DOI: 10.1007/s13238-019-0639-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
441 Shin HJ, Chung H, Kim HC. Correlation of foveal microstructural changes with vision after anti-vascular endothelial growth factor therapy in age-related macular degeneration. Retina 2013;33:964-70. [PMID: 23348865 DOI: 10.1097/IAE.0b013e3182835f70] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
442 Vokes SA, Krieg PA. Vascular Molecular Embryology. In: Lanzer P, editor. PanVascular Medicine. Berlin: Springer Berlin Heidelberg; 2015. pp. 27-51. [DOI: 10.1007/978-3-642-37078-6_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
443 Han JH, Jung J, Hwang L, Ko IG, Nam OH, Kim MS, Lee JW, Choi BJ, Lee DW. Anti-inflammatory effect of polydeoxyribonucleotide on zoledronic acid-pretreated and lipopolysaccharide-stimulated RAW 264.7 cells. Exp Ther Med 2018;16:400-5. [PMID: 29896266 DOI: 10.3892/etm.2018.6186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
444 Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, Park SR, Lim HY, Yamada Y, Wu J, Langer B, Starnawski M, Kang Y. Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study. JCO 2011;29:3968-76. [DOI: 10.1200/jco.2011.36.2236] [Cited by in Crossref: 733] [Cited by in F6Publishing: 436] [Article Influence: 66.6] [Reference Citation Analysis]
445 Tammela T, Petrova TV, Alitalo K. Molecular lymphangiogenesis: new players. Trends Cell Biol 2005;15:434-41. [PMID: 16005628 DOI: 10.1016/j.tcb.2005.06.004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
446 Remaut K, Sanders NN, De Geest BG, Braeckmans K, Demeester J, De Smedt SC. Nucleic acid delivery: Where material sciences and bio-sciences meet. Materials Science and Engineering: R: Reports 2007;58:117-61. [DOI: 10.1016/j.mser.2007.06.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
447 Kim BH, Lee Y, Yoo H, Cui M, Lee S, Kim SY, Cho JU, Lee H, Yang BS, Kwon YG, Choi S, Kim TY. Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling. Exp Dermatol 2015;24:503-9. [PMID: 25808463 DOI: 10.1111/exd.12698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
448 Geng B, Zhu Y, Yuan Y, Bai J, Dou Z, Sui A, Luo W. Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis. Front Oncol 2021;11:714646. [PMID: 34476217 DOI: 10.3389/fonc.2021.714646] [Reference Citation Analysis]
449 Kugeratski FG, Atkinson SJ, Neilson LJ, Lilla S, Knight JRP, Serneels J, Juin A, Ismail S, Bryant DM, Markert EK, Machesky LM, Mazzone M, Sansom OJ, Zanivan S. Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling. Sci Signal. 2019;12. [PMID: 30723174 DOI: 10.1126/scisignal.aan8247] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
450 Tozer GM, Bicknell R. Therapeutic targeting of the tumor vasculature. Seminars in Radiation Oncology 2004;14:222-32. [DOI: 10.1016/j.semradonc.2004.04.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
451 Trentin D, Hall H, Wechsler S, Hubbell JA. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A 2006;103:2506-11. [PMID: 16477043 DOI: 10.1073/pnas.0505964102] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 6.6] [Reference Citation Analysis]
452 Zhang J, Liu CY, Wan Y, Peng L, Li WF, Qiu JX. Long non-coding RNA H19 promotes the proliferation of fibroblasts in keloid scarring. Oncol Lett 2016;12:2835-9. [PMID: 27698867 DOI: 10.3892/ol.2016.4931] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
453 Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM. Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 2003;171:4340-51. [PMID: 14530359 DOI: 10.4049/jimmunol.171.8.4340] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]
454 Mehta G, Macdonald S, Cronberg A, Rosselli M, Khera-Butler T, Sumpter C, Al-Khatib S, Jain A, Maurice J, Charalambous C, Gander A, Ju C, Hakan T, Sherwood R, Nair D, Jalan R, Moore KP. Short-term abstinence from alcohol and changes in cardiovascular risk factors, liver function tests and cancer-related growth factors: a prospective observational study. BMJ Open 2018;8:e020673. [PMID: 29730627 DOI: 10.1136/bmjopen-2017-020673] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
455 Jones KA, Gilder AS, Lam MS, Du N, Banki MA, Merati A, Pizzo DP, VandenBerg SR, Gonias SL. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Neuro Oncol 2016;18:667-78. [PMID: 26420897 DOI: 10.1093/neuonc/nov243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
456 Suzuki H, Watabe T, Kato M, Miyazawa K, Miyazono K. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell–derived vascular progenitor cells into endothelial cells. Blood 2005;105:2372-9. [DOI: 10.1182/blood-2004-07-2547] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
457 Aicart-Ramos C, Sánchez-Ruiloba L, Gómez-Parrizas M, Zaragoza C, Iglesias T, Rodríguez-Crespo I. Protein kinase D activity controls endothelial nitric oxide synthesis. J Cell Sci 2014;127:3360-72. [PMID: 24928905 DOI: 10.1242/jcs.148601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
458 Carlsson L, Clarke JC, Yen C, Gregoire F, Albery T, Billger M, Egnell AC, Gan LM, Jennbacken K, Johansson E, Linhardt G, Martinsson S, Sadiq MW, Witman N, Wang QD, Chen CH, Wang YP, Lin S, Ticho B, Hsieh PCH, Chien KR, Fritsche-Danielson R. Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine. Mol Ther Methods Clin Dev 2018;9:330-46. [PMID: 30038937 DOI: 10.1016/j.omtm.2018.04.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 13.0] [Reference Citation Analysis]
459 Nomura S, Iwata S, Hatano R, Komiya E, Dang NH, Iwao N, Ohnuma K, Morimoto C. Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains. Biochem Biophys Res Commun 2016;474:111-7. [PMID: 27103437 DOI: 10.1016/j.bbrc.2016.04.081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
460 Liu W, Borriello L, Allain B, Pavoni S, Lopez N, Hermine O, Garbay C, Raynaud F, Lepelletier Y, Demange L. New Peptides Structurally Related to VEGF-A165 Exon-7 and -8 Encoded Domains Antagonize Its Binding to NRP-1 and VEGF-R1. Int J Pept Res Ther 2015;21:117-24. [DOI: 10.1007/s10989-014-9436-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
461 Dhakal HP, Nesland JM, Førsund M, Trope CG, Holm R. Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact. BMC Cancer 2013;13:506. [PMID: 24165149 DOI: 10.1186/1471-2407-13-506] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
462 Fay F, Scott CJ. Antibody-targeted nanoparticles for cancer therapy. Immunotherapy 2011;3:381-94. [DOI: 10.2217/imt.11.5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 9.3] [Reference Citation Analysis]
463 Ball SG, Shuttleworth CA, Kielty CM. Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med. 2007;11:1012-1030. [PMID: 17979880 DOI: 10.1111/j.1582-4934.2007.00120.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 7.5] [Reference Citation Analysis]
464 Dai J, Liu Y, Jia H, Zhou YD, Nagle DG. Benzochromenones from the marine crinoid Comantheria rotula inhibit hypoxia-inducible factor-1 (HIF-1) in cell-based reporter assays and differentially suppress the growth of certain tumor cell lines. J Nat Prod 2007;70:1462-6. [PMID: 17844994 DOI: 10.1021/np070224w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
465 Minegishi H, Futamura Y, Fukashiro S, Muroi M, Kawatani M, Osada H, Nakamura H. Methyl 3-((6-methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate (GN39482) as a tubulin polymerization inhibitor identified by MorphoBase and ChemProteoBase profiling methods. J Med Chem 2015;58:4230-41. [PMID: 25938266 DOI: 10.1021/acs.jmedchem.5b00035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
466 Regier MC, Montanez-Sauri SI, Schwartz MP, Murphy WL, Beebe DJ, Sung KE. The Influence of Biomaterials on Cytokine Production in 3D Cultures. Biomacromolecules 2017;18:709-18. [PMID: 28157290 DOI: 10.1021/acs.biomac.6b01469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
467 Giganti G, Atif M, Mohseni Y, Mastronicola D, Grageda N, Povoleri GA, Miyara M, Scottà C. Treg cell therapy: How cell heterogeneity can make the difference. Eur J Immunol 2021;51:39-55. [PMID: 33275279 DOI: 10.1002/eji.201948131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
468 Kopp S, Slumstrup L, Corydon TJ, Sahana J, Aleshcheva G, Islam T, Magnusson NE, Wehland M, Bauer J, Infanger M, Grimm D. Identifications of novel mechanisms in breast cancer cells involving duct-like multicellular spheroid formation after exposure to the Random Positioning Machine. Sci Rep 2016;6:26887. [PMID: 27230828 DOI: 10.1038/srep26887] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
469 Hoier B, Hellsten Y. Exercise-induced capillary growth in human skeletal muscle and the dynamics of VEGF. Microcirculation. 2014;21:301-314. [PMID: 24450403 DOI: 10.1111/micc.12117] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 12.7] [Reference Citation Analysis]
470 Kao JT, Feng CL, Yu CJ, Tsai SM, Hsu PN, Chen YL, Wu YY. IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study. BMC Gastroenterol 2015;15:50. [PMID: 25908103 DOI: 10.1186/s12876-015-0283-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
471 Vedenko A, Panara K, Goldstein G, Ramasamy R, Arora H. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms. Adv Exp Med Biol 2020;1277:143-58. [PMID: 33119871 DOI: 10.1007/978-3-030-50224-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
472 Shih HC, Lee TA, Wu HM, Ko PL, Liao WH, Tung YC. Microfluidic Collective Cell Migration Assay for Study of Endothelial Cell Proliferation and Migration under Combinations of Oxygen Gradients, Tensions, and Drug Treatments. Sci Rep 2019;9:8234. [PMID: 31160651 DOI: 10.1038/s41598-019-44594-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
473 Knetsch ML, Koole LH. VEGF-E enhances endothelialization and inhibits thrombus formation on polymeric surfaces. J Biomed Mater Res A 2010;93:77-85. [PMID: 19484771 DOI: 10.1002/jbm.a.32538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
474 Feigl B. Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis. Progress in Retinal and Eye Research 2009;28:63-86. [DOI: 10.1016/j.preteyeres.2008.11.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
475 Ambrosi D, Bussolino F, Preziosi L. A Review of Vasculogenesis Models. Journal of Theoretical Medicine 2005;6:1-19. [DOI: 10.1080/1027366042000327098] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
476 Amirfakhryan H. Vaccination against atherosclerosis: An overview. Hellenic Journal of Cardiology 2020;61:78-91. [DOI: 10.1016/j.hjc.2019.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
477 Li M, Zhao C. Study on Tibetan Chicken embryonic adaptability to chronic hypoxia by revealing differential gene expression in heart tissue. SCI CHINA SER C 2009;52:284-95. [DOI: 10.1007/s11427-009-0005-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
478 Dong G, Guo X, Fu X, Wan S, Zhou F, Myers RE, Bao G, Burkart A, Yang H, Xing J. Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer. Cancer Sci 2012;103:561-8. [PMID: 22182247 DOI: 10.1111/j.1349-7006.2011.02194.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
479 Mariniello B, Rosato A, Zuccolotto G, Rubin B, Cicala MV, Finco I, Iacobone M, Frigo AC, Fassina A, Pezzani R, Mantero F. Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models. Endocr Relat Cancer 2012;19:527-39. [PMID: 22673336 DOI: 10.1530/ERC-11-0337] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
480 Hirokoshi K, Maeshima Y, Kobayashi K, Matsuura E, Sugiyama H, Yamasaki Y, Masuyama H, Hiramatsu Y, Makino H. Elevated Serum sFlt-1/Ang-2 Ratio in Women with Preeclampsia. Nephron Clin Pract 2007;106:c43-50. [DOI: 10.1159/000101483] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
481 Medeiros R, Rodrigues GB, Figueiredo CP, Rodrigues EB, Grumman A, Menezes-de-lima O, Passos GF, Calixto JB. Molecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A 4 in Endotoxin-Induced Uveitis. Mol Pharmacol 2008;74:154-61. [DOI: 10.1124/mol.108.046870] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
482 Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J Clin Invest 2006;116:369-77. [PMID: 16424942 DOI: 10.1172/JCI25964] [Cited by in Crossref: 81] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
483 Szajewski M, Kruszewski WJ, Lakomy J, Ciesielski M, Kawecki K, Szefel J. VEGF-C expression is not a prognostic factor in locally advanced colon adenocarcinoma. Contemp Oncol (Pozn) 2015;19:446-50. [PMID: 26843840 DOI: 10.5114/wo.2015.56649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
484 Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, Madri JA, Lu TT. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol 2008;181:3887-96. [PMID: 18768843 DOI: 10.4049/jimmunol.181.6.3887] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 7.1] [Reference Citation Analysis]
485 Diana D, Di Stasi R, De Rosa L, Isernia C, D'andrea LD, Fattorusso R. Structural investigation of the VEGF receptor interaction with a helical antagonist peptide: STRUCTURAL STUDIES OF VEGF RECEPTOR BOUND TO AN ANTAGONIST PEPTIDE. J Pept Sci 2013;19:214-9. [DOI: 10.1002/psc.2480] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
486 Zhu CQ, Shih W, Ling CH, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59:790-800. [PMID: 16873561 DOI: 10.1136/jcp.2005.031351] [Cited by in Crossref: 130] [Cited by in F6Publishing: 111] [Article Influence: 8.1] [Reference Citation Analysis]
487 Świdrowska-Jaros J, Smolewska E. A fresh look at angiogenesis in juvenile idiopathic arthritis. Cent Eur J Immunol 2018;43:325-30. [PMID: 30863199 DOI: 10.5114/ceji.2018.80052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
488 Kaplan O, Zárubová J, Mikulová B, Filová E, Bártová J, Bačáková L, Brynda E. Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones. PLoS One 2016;11:e0163697. [PMID: 27716773 DOI: 10.1371/journal.pone.0163697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
489 Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM. Angiogenic imbalances: the obstetric perspective. American Journal of Obstetrics and Gynecology 2010;203:17.e1-8. [DOI: 10.1016/j.ajog.2009.10.891] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
490 Lee JE, Kim JY, Jung JH, Shin DH, Park SW. Induction of vascular endothelial growth factor receptor expression in human umbilical vein endothelial cells after repeated bevacizumab treatment in vitro. Int J Ophthalmol 2017;10:1064-8. [PMID: 28730107 DOI: 10.18240/ijo.2017.07.07] [Reference Citation Analysis]
491 Momeny M, Sankanian G, Hamzehlou S, Yousefi H, Esmaeili F, Alishahi Z, Karimi B, Zandi Z, Shamsaiegahkani S, Sabourinejad Z, Kashani B, Nasrollahzadeh A, Mousavipak SH, Mousavi SA, Ghaffari SH. Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells. Eur J Pharmacol 2020;882:173298. [PMID: 32593665 DOI: 10.1016/j.ejphar.2020.173298] [Reference Citation Analysis]
492 Ji Z, Ahmed AA, Albert DH, Bouska JJ, Bousquet PF, Cunha GA, Diaz G, Glaser KB, Guo J, Harris CM, Li J, Marcotte PA, Moskey MD, Oie T, Pease L, Soni NB, Stewart KD, Davidsen SK, Michaelides MR. 3-Amino-benzo[ d ]isoxazoles as Novel Multitargeted Inhibitors of Receptor Tyrosine Kinases. J Med Chem 2008;51:1231-41. [DOI: 10.1021/jm701096v] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
493 Qi JW, Qin TT, Xu LX, Zhang K, Yang GL, Li J, Xiao HY, Zhang ZS, Li LY. TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1. Proc Natl Acad Sci U S A 2013;110:13863-8. [PMID: 23918400 DOI: 10.1073/pnas.1304529110] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
494 Zhuang G, Yu K, Jiang Z, Chung A, Yao J, Ha C, Toy K, Soriano R, Haley B, Blackwood E, Sampath D, Bais C, Lill JR, Ferrara N. Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases. Sci Signal 2013;6:ra25. [PMID: 23592840 DOI: 10.1126/scisignal.2003572] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
495 VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW Jr, Kittles RA, Kidd LC. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate 2010;70:341-52. [PMID: 19908237 DOI: 10.1002/pros.21067] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
496 Wang H, Lapek J, Fujimura K, Strnadel J, Liu B, Gonzalez DJ, Zhang W, Watson F, Yu V, Liu C, Melo CM, Miller YI, Elliott KC, Cheresh DA, Klemke RL. Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription. Cell Discov 2018;4:26. [PMID: 29872538 DOI: 10.1038/s41421-018-0024-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
497 Teng L, Jin K, He K, Wang H, Cao J, Yu D. Advances in Combination of Antiangiogenic Agents Targeting VEGF-binding and Conventional Chemotherapy and Radiation for Cancer Treatment. Journal of the Chinese Medical Association 2010;73:281-8. [DOI: 10.1016/s1726-4901(10)70062-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
498 Pyriochou A, Tsigkos S, Vassilakopoulos T, Cottin T, Zhou Z, Gourzoulidou E, Roussos C, Waldmann H, Giannis A, Papapetropoulos A. Anti-angiogenic properties of a sulindac analogue. Br J Pharmacol 2007;152:1207-14. [PMID: 17965739 DOI: 10.1038/sj.bjp.0707534] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
499 Fisher T, Galanti G, Lavie G, Jacob-Hirsch J, Kventsel I, Zeligson S, Winkler R, Simon AJ, Amariglio N, Rechavi G, Toren A. Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme. Cancer J 2007;13:335-44. [PMID: 17921733 DOI: 10.1097/PPO.0b013e318157053f] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
500 Prior SJ, McKenzie MJ, Joseph LJ, Ivey FM, Macko RF, Hafer-Macko CE, Ryan AS. Reduced skeletal muscle capillarization and glucose intolerance. Microcirculation 2009;16:203-12. [PMID: 19225985 DOI: 10.1080/10739680802502423] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
501 Ghazizadeh H, Avan A, Fazilati M, Azimi-nezhad M, Tayefi M, Ghasemi F, Mehramiz M, Moohebati M, Ebrahimi M, Mirhafez SR, Ferns GA, Esmaeili H, Pasdar A, Ghayour-mobarhan M. Association of rs6921438 A<G with serum vascular endothelial growth factor concentrations in patients with metabolic syndrome. Gene 2018;667:70-5. [DOI: 10.1016/j.gene.2018.05.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
502 Piechnik A, Dmoszynska A, Omiotek M, Mlak R, Kowal M, Stilgenbauer S, Bullinger L, Giannopoulos K. The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients. Int J Cancer 2013;133:1489-96. [PMID: 23447383 DOI: 10.1002/ijc.28135] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
503 Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, Kusanovic JP, Erez O, Than NG, Hassan SS, Romero R. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 2008;21:25-40. [PMID: 18175242 DOI: 10.1080/14767050701832833] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
504 Liu L, Li Z, Feng G, You W, Li J. Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C, -D and associated with shorter survival in gastric cancer. Pathol Int. 2007;57:712-718. [PMID: 17922682 DOI: 10.1111/j.1440-1827.2007.02162.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
505 O'Connor JP, Carano RA, Clamp AR, Ross J, Ho CC, Jackson A, Parker GJ, Rose CJ, Peale FV, Friesenhahn M, Mitchell CL, Watson Y, Roberts C, Hope L, Cheung S, Reslan HB, Go MA, Pacheco GJ, Wu X, Cao TC, Ross S, Buonaccorsi GA, Davies K, Hasan J, Thornton P, del Puerto O, Ferrara N, van Bruggen N, Jayson GC. Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging. Clin Cancer Res 2009;15:6674-82. [PMID: 19861458 DOI: 10.1158/1078-0432.CCR-09-0731] [Cited by in Crossref: 118] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
506 Abraham S, Rangaswamy SP, Chinnaiah A. Evaluation of recombinant human vascular endothelial growth factor VEGF121-loaded poly-l-lactide microparticles as a controlled release delivery system. Turk J Biol 2020;44:34-47. [PMID: 32123494 DOI: 10.3906/biy-1908-32] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
507 Su F, Geng J, Li X, Qiao C, Luo L, Feng J, Dong X, Lv M. SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model. Oncol Rep 2017;38:2677-84. [PMID: 29048687 DOI: 10.3892/or.2017.5998] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
508 Tran TA, Kinch L, Peña-Llopis S, Kockel L, Grishin N, Jiang H, Brugarolas J. Platelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1. Mol Cell Biol 2013;33:3762-79. [PMID: 23878397 DOI: 10.1128/MCB.01570-12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
509 Zhang H, Wang R, Wang M. miR-331-3p suppresses cell invasion and migration in colorectal carcinoma by directly targeting NRP2. Oncol Lett 2019;18:6501-8. [PMID: 31807170 DOI: 10.3892/ol.2019.11029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
510 Chen M, Gui Y, Zhu H, Zhang Z, Lin H. Proangiogenic penibishexahydroxanthone A from the marine-derived fungus Penicillium sp. ZZ486A. Tetrahedron Letters 2019;60:1393-6. [DOI: 10.1016/j.tetlet.2019.04.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
511 Ravalli A, Voccia D, Palchetti I, Marrazza G. Electrochemical, Electrochemiluminescence, and Photoelectrochemical Aptamer-Based Nanostructured Sensors for Biomarker Analysis. Biosensors (Basel) 2016;6:E39. [PMID: 27490578 DOI: 10.3390/bios6030039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
512 Kruck S, Merseburger AS, Stenzl A, Bedke J. How far is the horizon? From current targets to future drugs in advanced renal cancer. World J Urol 2014;32:69-77. [PMID: 23657355 DOI: 10.1007/s00345-013-1096-1] [Reference Citation Analysis]
513 Miura S, Maemondo M, Iwashima A, Harada T, Sugawara S, Kobayashi K, Inoue A, Nakagawa T, Takiguchi Y, Watanabe H, Ishida T, Terada M, Kagamu H, Gemma A, Yoshizawa H. A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016). Invest New Drugs 2017;35:227-34. [PMID: 28150074 DOI: 10.1007/s10637-017-0436-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
514 Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res 2018;62:77-119. [PMID: 28958885 DOI: 10.1016/j.preteyeres.2017.09.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
515 Asikainen TM, Ahmad A, Schneider BK, White CW. Effect of Preterm Birth on Hypoxia-Inducible Factors and Vascular Endothelial Growth Factor in Primate Lungs. Pediatr Pulmonol 2005;40:538-46. [DOI: 10.1002/ppul.20321] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
516 Yang M, Huang J, Zhang S, Zhao X, Feng D, Feng X. Melatonin mitigated circadian disruption and cardiovascular toxicity caused by 6-benzylaminopurine exposure in zebrafish. Ecotoxicol Environ Saf 2021;223:112555. [PMID: 34332249 DOI: 10.1016/j.ecoenv.2021.112555] [Reference Citation Analysis]
517 Narayanan S, Srinivas S. Incorporating VEGF-targeted therapy in advanced urothelial cancer. Ther Adv Med Oncol 2017;9:33-45. [PMID: 28203296 DOI: 10.1177/1758834016667179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
518 Shamloo A, Xu H, Heilshorn S. Mechanisms of vascular endothelial growth factor-induced pathfinding by endothelial sprouts in biomaterials. Tissue Eng Part A 2012;18:320-30. [PMID: 21888475 DOI: 10.1089/ten.tea.2011.0323] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
519 SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Semin Ophthalmol 2013;28:165-72. [PMID: 23697619 DOI: 10.3109/08820538.2012.730103] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
520 Lim S, Zhang Y, Zhang D, Chen F, Hosaka K, Feng N, Seki T, Andersson P, Li J, Zang J, Sun B, Cao Y. VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobilization. Cell Rep 2014;9:569-80. [PMID: 25310988 DOI: 10.1016/j.celrep.2014.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
521 Lee SY, Chung SM. Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression. Vascul Pharmacol 2007;47:313-8. [PMID: 17931982 DOI: 10.1016/j.vph.2007.08.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
522 Aisha AF, Ismail Z, Abu-Salah KM, Siddiqui JM, Ghafar G, Abdul Majid AM. Syzygium campanulatum korth methanolic extract inhibits angiogenesis and tumor growth in nude mice. BMC Complement Altern Med 2013;13:168. [PMID: 23842450 DOI: 10.1186/1472-6882-13-168] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
523 Sison K, Eremina V, Baelde H, Min W, Hirashima M, Fantus IG, Quaggin SE. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol. 2010;21:1691-1701. [PMID: 20688931 DOI: 10.1681/asn.2010030295] [Cited by in Crossref: 175] [Cited by in F6Publishing: 109] [Article Influence: 14.6] [Reference Citation Analysis]
524 Leppänen P, Kholová I, Mähönen AJ, Airenne K, Koota S, Mansukoski H, Närväinen J, Wirzenius M, Alhonen L, Jänne J, Alitalo K, Ylä-Herttuala S. Short and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice. PLoS One 2006;1:e13. [PMID: 17183639 DOI: 10.1371/journal.pone.0000013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
525 Boschen KE, Klintsova AY. Neurotrophins in the Brain: Interaction With Alcohol Exposure During Development. Vitam Horm 2017;104:197-242. [PMID: 28215296 DOI: 10.1016/bs.vh.2016.10.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
526 Jayasinghe C, Simiantonaki N, Kirkpatrick CJ. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis. BMC Cancer 2015;15:104. [PMID: 25880726 DOI: 10.1186/s12885-015-1130-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
527 Estrada CC, Maldonado A, Mallipattu SK. Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities. J Am Soc Nephrol 2019;30:187-200. [PMID: 30642877 DOI: 10.1681/ASN.2018080853] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
528 Anitua E, Prado R, Orive G. Bilateral sinus elevation evaluating plasma rich in growth factors technology: a report of five cases. Clin Implant Dent Relat Res 2012;14:51-60. [PMID: 20626759 DOI: 10.1111/j.1708-8208.2009.00233.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
529 Cioffi S, Martucciello S, Fulcoli FG, Bilio M, Ferrentino R, Nusco E, Illingworth E. Tbx1 regulates brain vascularization. Hum Mol Genet 2014;23:78-89. [PMID: 23945394 DOI: 10.1093/hmg/ddt400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
530 Martorell L, Gentile M, Rius J, Rodríguez C, Crespo J, Badimon L, Martínez-González J. The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia. Mol Cell Biol. 2009;29:5828-5842. [PMID: 19720740 DOI: 10.1128/mcb.00945-09] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
531 Reddy GK, Ramalingam S, Jain VK. Early Clinical Data with Small-Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitors. Clinical Lung Cancer 2004;6:74-6. [DOI: 10.1016/s1525-7304(11)70204-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
532 Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 2015;44-46:94-112. [PMID: 25912949 DOI: 10.1016/j.matbio.2015.04.004] [Cited by in Crossref: 193] [Cited by in F6Publishing: 194] [Article Influence: 27.6] [Reference Citation Analysis]
533 Wang Y, Wang L, Chen C, Chu X. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.Mol Cancer. 2018;17:22. [PMID: 29415727 DOI: 10.1186/s12943-018-0766-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
534 Tang N, Shi L, Yu Z, Dong P, Wang C, Huo X, Zhang B, Huang S, Deng S, Liu K, Ma T, Wang X, Wu L, Ma XC. Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway. Oncotarget 2016;7:3533-47. [PMID: 26657289 DOI: 10.18632/oncotarget.6514] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
535 Qian Z, Fei J, Zong S, Yang K, Li L, Liu R, Wang Z, Cui Y. In Situ Visualization and SERS Monitoring of the Interaction between Tumor and Endothelial Cells Using 3D Microfluidic Networks. ACS Sens 2020;5:208-16. [DOI: 10.1021/acssensors.9b02085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
536 Kamenskih TG. [A differentiated approach to analysis of retinal fluid and assessment of its effect on anti-VEGF therapy of neovascular age-related macular degeneration]. Vestn Oftalmol 2019;135:134-40. [PMID: 32015318 DOI: 10.17116/oftalma2019135061134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
537 Grabowska K, Puszko AK, Lipiński PF, Laskowska AK, Wileńska B, Witkowska E, Misicka A. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1. Bioorganic & Medicinal Chemistry Letters 2016;26:2843-6. [DOI: 10.1016/j.bmcl.2016.04.059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
538 Keane PA, Sadda SR. Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians. J Ophthalmol 2012;2012:483034. [PMID: 22220269 DOI: 10.1155/2012/483034] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
539 Saraswat D, Nehra S, Chaudhary K, CVS SP. Novel vascular endothelial growth factor blocker improves cellular viability and reduces hypobaric hypoxia-induced vascular leakage and oedema in rat brain. Clin Exp Pharmacol Physiol 2015;42:475-84. [PMID: 25752672 DOI: 10.1111/1440-1681.12387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
540 Wang W, Pan Z, Hu X, Li Z, Zhao Y, Yu AX. Vacuum-assisted closure increases ICAM-1, MIF, VEGF and collagen I expression in wound therapy. Exp Ther Med. 2014;7:1221-1226. [PMID: 24940415 DOI: 10.3892/etm.2014.1567] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
541 Tolnay E, Ghimessy ÁK, Juhász E, Sztancsik Z, Losonczy G, Dombi P, Vennes Z, Helf L, Csada E, Sárosi V. The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study. Oncol Lett 2019;17:1750-60. [PMID: 30675234 DOI: 10.3892/ol.2018.9766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
542 Isachenko V, Maettner R, Sterzik K, Strehler E, Kreinberg R, Hancke K, Roth S, Isachenko E. In-vitro culture of human embryos with mechanical micro-vibration increases implantation rates. Reproductive BioMedicine Online 2011;22:536-44. [DOI: 10.1016/j.rbmo.2011.02.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
543 Formisano L, Jansen VM, Marciano R, Bianco R. From Biology to Therapy: Improvements of Therapeutic Options in Lung Cancer. Anticancer Agents Med Chem 2018;18:1235-40. [PMID: 28901258 DOI: 10.2174/1871520617666170912123416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
544 Ghosh R, Lipson KL, Sargent KE, Mercurio AM, Hunt JS, Ron D, Urano F. Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One 2010;5:e9575. [PMID: 20221394 DOI: 10.1371/journal.pone.0009575] [Cited by in Crossref: 167] [Cited by in F6Publishing: 154] [Article Influence: 13.9] [Reference Citation Analysis]
545 Müller K, Ellenberger C, Schoon H. Histomorphological and immunohistochemical study of angiogenesis and angiogenic factors in the ovary of the mare. Research in Veterinary Science 2009;87:421-31. [DOI: 10.1016/j.rvsc.2009.04.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
546 Lanitis E, Kosti P, Ronet C, Cribioli E, Rota G, Spill A, Reichenbach P, Zoete V, Dangaj Laniti D, Coukos G, Irving M. VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding. J Immunother Cancer 2021;9:e002151. [PMID: 34389616 DOI: 10.1136/jitc-2020-002151] [Reference Citation Analysis]
547 Ren X, Akimoto J, Miyatake H, Tada S, Zhu L, Mao H, Isoshima T, Müller S, Kim SM, Zhou Y, Ito Y. Cell migration and growth induced by photo-immobilised vascular endothelial growth factor (VEGF) isoforms. J Mater Chem B 2019;7:4272-9. [DOI: 10.1039/c9tb00407f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
548 Shukunami C, Oshima Y, Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun 2005;333:299-307. [PMID: 15950187 DOI: 10.1016/j.bbrc.2005.05.133] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
549 da Silva Pereira MM, de Melo IMF, Braga VAÁ, Teixeira ÁAC, Wanderley-Teixeira V. Effect of swimming exercise, insulin-associated or not, on inflammatory cytokines, apoptosis, and collagen in diabetic rat placentas. Histochem Cell Biol 2022. [PMID: 35022821 DOI: 10.1007/s00418-021-02069-7] [Reference Citation Analysis]
550 Kwiatkowski S, Dołegowska B, Kwiatkowska E, Rzepka R, Marczuk N, Loj B, Torbè A. Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. J Perinat Med 2017;45:793-802. [PMID: 27865093 DOI: 10.1515/jpm-2016-0178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
551 Luttun A, Autiero M, Tjwa M, Carmeliet P. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? Biochim Biophys Acta 2004;1654:79-94. [PMID: 14984769 DOI: 10.1016/j.bbcan.2003.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 0.4] [Reference Citation Analysis]
552 Nethi SK, Barui AK, Mukherjee S, Patra CR. Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic Therapy. Antioxid Redox Signal 2019;30:786-809. [PMID: 29943661 DOI: 10.1089/ars.2017.7383] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
553 Horsman MR, Vaupel P. Pathophysiological Basis for the Formation of the Tumor Microenvironment. Front Oncol 2016;6:66. [PMID: 27148472 DOI: 10.3389/fonc.2016.00066] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 14.3] [Reference Citation Analysis]
554 Kontopodis E, Kentepozidis N, Christophyllakis C, Boukovinas I, Kalykaki A, Kalbakis K, Vamvakas L, Agelaki S, Kotsakis A, Vardakis N, Georgoulias V, Mavroudis D. Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer. Cancer Chemother Pharmacol 2015;75:153-60. [DOI: 10.1007/s00280-014-2628-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
555 Chen WC, Qiu JT, Lai CH, Huang HJ, Lin CT, Chen MY, Chou HH, Huang KG, Chang TC. Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan. PLoS One 2017;12:e0175703. [PMID: 28467466 DOI: 10.1371/journal.pone.0175703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
556 Chesnokov MS, Khesina PA, Shavochkina DA, Kustova IF, Dyakov LM, Morozova OV, Mugue NS, Kudashkin NE, Moroz EA, Patyutko YI, Lazarevich NL. Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma. PeerJ 2018;6:e4915. [PMID: 29888133 DOI: 10.7717/peerj.4915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
557 Dasari A, Messersmith WA. Should We Perform a New Adjuvant Trial with Bevacizumab? Curr Colorectal Cancer Rep 2011;7:218-26. [DOI: 10.1007/s11888-011-0101-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
558 Song ZY, Wen SQ, Peng JP, Huang X, Qian KD. Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer. World J Gastroenterol 2004; 10(9): 1250-1255 [PMID: 15112337 DOI: 10.3748/wjg.v10.i9.1250] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
559 Znati S, Carter R, Vasquez M, Westhorpe A, Shahbakhti H, Prince J, Vlckova P, De Vellis C, Bascal Z, Loizidou M, Sharma RA. Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib. Cancers (Basel) 2020;12:E1878. [PMID: 32668592 DOI: 10.3390/cancers12071878] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
560 Lai E, Cascinu S, Scartozzi M. Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice. Front Oncol 2021;11:637823. [PMID: 34041019 DOI: 10.3389/fonc.2021.637823] [Reference Citation Analysis]
561 Galvagni F, Baldari CT, Oliviero S, Orlandini M. An apical actin-rich domain drives the establishment of cell polarity during cell adhesion. Histochem Cell Biol 2012;138:419-33. [PMID: 22644377 DOI: 10.1007/s00418-012-0965-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
562 Pant V, Yadav BK, Sharma J. A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia. BMC Pregnancy Childbirth 2019;19:266. [PMID: 31345176 DOI: 10.1186/s12884-019-2399-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
563 Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW, Stupp SI. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci U S A 2011;108:13438-43. [PMID: 21808036 DOI: 10.1073/pnas.1016546108] [Cited by in Crossref: 228] [Cited by in F6Publishing: 207] [Article Influence: 20.7] [Reference Citation Analysis]
564 Wilgus TA. Vascular Endothelial Growth Factor and Cutaneous Scarring. Adv Wound Care (New Rochelle) 2019;8:671-8. [PMID: 31750015 DOI: 10.1089/wound.2018.0796] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
565 Ohtsu A, Fuse N, Yoshino T, Tahara M, Doi T. Future perspectives of chemotherapy for advanced gastric cancer. Gastric Cancer 2009;12:60-6. [DOI: 10.1007/s10120-008-0461-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
566 Zahid S, Shah AT, Jamal A, Chaudhry AA, Khan AS, Khan AF, Muhammad N, Rehman IU. Biological behavior of bioactive glasses and their composites. RSC Adv 2016;6:70197-214. [DOI: 10.1039/c6ra07819b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
567 Robinson CJ, Mulloy B, Gallagher JT, Stringer SE. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem 2006;281:1731-40. [PMID: 16258170 DOI: 10.1074/jbc.M510760200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
568 Zeng N, Tong B, Zhang X, Dou Y, Wu X, Xia Y, Dai Y, Wei Z. Antiarthritis Effect of Morin is Associated with Inhibition of Synovial Angiogensis: MORIN ALLEVIATED ARTHRITIS. Drug Dev Res 2015;76:463-73. [DOI: 10.1002/ddr.21282] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
569 Taniguchi K, Ishizaki T, Ayada T, Sugiyama Y, Wakabayashi Y, Sekiya T, Nakagawa R, Yoshimura A. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. Cancer Science 2009;100:1648-54. [DOI: 10.1111/j.1349-7006.2009.01214.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
570 Müller SM, Terszowski G, Blum C, Haller C, Anquez V, Kuschert S, Carmeliet P, Augustin HG, Rodewald HR. Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture. Proc Natl Acad Sci U S A 2005;102:10587-92. [PMID: 16027358 DOI: 10.1073/pnas.0502752102] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
571 Bauer AL, Jackson TL, Jiang Y, Rohlf T. Receptor cross-talk in angiogenesis: mapping environmental cues to cell phenotype using a stochastic, Boolean signaling network model. J Theor Biol 2010;264:838-46. [PMID: 20307549 DOI: 10.1016/j.jtbi.2010.03.025] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
572 Sanchis E, Cristofolini A, Merkis C. Porcine placental immunoexpression of vascular endothelial growth factor, placenta growth factor, Flt-1 and Flk-1. Biotechnic & Histochemistry 2015;90:486-94. [DOI: 10.3109/10520295.2015.1019927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
573 Sandström M, Johansson M, Bergström P, Bergenheim AT, Henriksson R. Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model. J Neurooncol 2008;88:1-9. [DOI: 10.1007/s11060-008-9527-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
574 Wannenes F, Ciafré SA, Niola F, Frajese G, Farace MG. Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo. Cancer Gene Ther. 2005;12:926-934. [PMID: 15956982 DOI: 10.1038/sj.cgt.7700862] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
575 Huang SW, Lien JC, Kuo SC, Huang TF. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. Oncotarget 2016;7:63124-37. [PMID: 27517319 DOI: 10.18632/oncotarget.11152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
576 Meyer N, Akdis CA. Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep 2013;13:1-9. [PMID: 23076420 DOI: 10.1007/s11882-012-0317-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
577 Cheng S, Zhang X, Feng Q, Chen J, Shen L, Yu P, Yang L, Chen D, Zhang H, Sun W, Chen X. Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway. Life Sciences 2019;227:82-93. [DOI: 10.1016/j.lfs.2019.04.040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
578 Holleran G, McNamara D. An overview of angiodysplasia: Management and patient prospects. Expert Rev Gastroenterol Hepatol. 2018;12:863-872. [PMID: 30028221 DOI: 10.1080/17474124.2018.1503532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
579 Kalkunte S, Huang Z, Lippe E, Kumar S, Robertson LW, Sharma S. Polychlorinated biphenyls target Notch/Dll and VEGF R2 in the mouse placenta and human trophoblast cell lines for their anti-angiogenic effects. Sci Rep 2017;7:39885. [PMID: 28071720 DOI: 10.1038/srep39885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
580 McKenzie S, Sakamoto S, Kyprianou N. Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene 2008;27:7171-9. [PMID: 18931702 DOI: 10.1038/onc.2008.321] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
581 Brosius FC, Coward RJ. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease. Adv Chronic Kidney Dis 2014;21:304-10. [PMID: 24780459 DOI: 10.1053/j.ackd.2014.03.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
582 Starnes SL, Pathrose P, Wang J, Succop P, Morris JC, Bridges J, Kupert EY, Anderson M. Clinical and Molecular Predictors of Recurrence in Stage I Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery 2012;93:1606-12. [DOI: 10.1016/j.athoracsur.2012.01.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
583 Halin C, Tobler NE, Vigl B, Brown LF, Detmar M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood. 2007;110:3158-3167. [PMID: 17625067 DOI: 10.1182/blood-2007-01-066811] [Cited by in Crossref: 131] [Cited by in F6Publishing: 130] [Article Influence: 8.7] [Reference Citation Analysis]
584 Ronnekleiv-Kelly SM, Kennedy GD. Management of stage IV rectal cancer: Palliative options. World J Gastroenterol 2011; 17(7): 835-847 [PMID: 21412493 DOI: 10.3748/wjg.v17.i7.835] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
585 Aamodt KI, Powers AC. Signals in the pancreatic islet microenvironment influence β-cell proliferation. Diabetes Obes Metab 2017;19 Suppl 1:124-36. [PMID: 28880471 DOI: 10.1111/dom.13031] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 15.8] [Reference Citation Analysis]
586 Ramaswamy V, Monsalve A, Sautina L, Segal MS, Dobson J, Allen JB. DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist. Nucleic Acid Ther 2015;25:227-34. [PMID: 26125598 DOI: 10.1089/nat.2014.0519] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
587 Chen Y, Gao A, Bai L, Wang Y, Wang X, Zhang X, Huang X, Hang R, Tang B, Chu PK. Antibacterial, osteogenic, and angiogenic activities of SrTiO 3 nanotubes embedded with Ag 2 O nanoparticles. Materials Science and Engineering: C 2017;75:1049-58. [DOI: 10.1016/j.msec.2017.03.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
588 Watanabe M, Boyer JL, Crystal RG. Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema. Hum Gene Ther 2009;20:598-610. [PMID: 19254174 DOI: 10.1089/hum.2008.169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
589 Mu X, Zhao T, Xu C, Shi W, Geng B, Shen J, Zhang C, Pan J, Yang J, Hu S. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget. 2017;8:13174-13185. [PMID: 28061458 DOI: 10.18632/oncotarget.14485] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
590 Liu R, Liu Y, Zhou YD, Nagle DG. Molecular-targeted antitumor agents. 15. Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells. J Nat Prod 2007;70:1741-5. [PMID: 17958397 DOI: 10.1021/np070206e] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
591 Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One. 2006;1:e116. [PMID: 17205120 DOI: 10.1371/journal.pone.0000116] [Cited by in Crossref: 456] [Cited by in F6Publishing: 448] [Article Influence: 28.5] [Reference Citation Analysis]
592 Brahami N, Subramaniam S, Al-Ddafari MS, Elkaim C, Harmand PO, Sari BE, Lefranc G, Aribi M. Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src. J Negat Results Biomed 2017;16:9. [PMID: 28316284 DOI: 10.1186/s12952-017-0072-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
593 Multhoff G, Radons J, Vaupel P. Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance. Cancers (Basel) 2014;6:813-28. [PMID: 24717239 DOI: 10.3390/cancers6020813] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
594 Lee J, Yang DS, Han SI, Yun JH, Kim IW, Kim SJ, Kim JH. Aqueous Extraction of Citrus unshiu Peel Induces Proangiogenic Effects Through the FAK and ERK1/2 Signaling Pathway in Human Umbilical Vein Endothelial Cells. J Med Food 2016;19:569-77. [PMID: 27266341 DOI: 10.1089/jmf.2015.3584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
595 Hoang MV, Nagy JA, Fox JE, Senger DR. Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis. PLoS One 2010;5:e13612. [PMID: 21049044 DOI: 10.1371/journal.pone.0013612] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
596 Manegold C. Bevacizumab for the treatment of advanced non-small-cell lung cancer. Expert Rev Anticancer Ther 2008;8:689-99. [PMID: 18471042 DOI: 10.1586/14737140.8.5.689] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
597 Marton S, Reyes-Darias JA, Sánchez-Luque FJ, Romero-López C, Berzal-Herranz A. In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules. Molecules 2010;15:4610-38. [PMID: 20657381 DOI: 10.3390/molecules15074610] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
598 Rossi A, Maione P, Ferrara C, Del Gaizo F, Guerriero C, Nicolella D, Palazzolo G, Falanga M, Colantuoni G, Gridelli C. New angiogenic agents and non-small cell lung cancer: current results and future development. Targ Oncol 2007;2:211-23. [DOI: 10.1007/s11523-007-0060-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
599 Yao ZY, Feng BW, Liu CS, Liu YM, Zhou HY, Zhang XH, Jian MQ, Mo JL, Liang YJ, Chen L, Liu XQ, Chen YL, Zhang ZS, He SR. The Application of a Bone Marrow Mesenchymal Stem Cell Membrane in the Vascularization of a Decellularized Tracheal Scaffold. Stem Cells Int 2021;2021:6624265. [PMID: 33747094 DOI: 10.1155/2021/6624265] [Reference Citation Analysis]
600 Wang B, Zhao J, Zhang P. Gene signatures in osteoarthritic acetabular labrum using microarray analysis. Int J Rheum Dis 2017;20:1927-34. [PMID: 26833791 DOI: 10.1111/1756-185X.12810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
601 González-Muniesa P, Garcia-Gerique L, Quintero P, Arriaza S, Lopez-Pascual A, Martinez JA. Effects of Hyperoxia on Oxygen-Related Inflammation with a Focus on Obesity. Oxid Med Cell Longev 2015;2015:8957827. [PMID: 26697142 DOI: 10.1155/2016/8957827] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
602 Varayoud J, Ramos JG, Muñoz-de-Toro M, Luque EH. Long-lasting effects of neonatal bisphenol A exposure on the implantation process. Vitam Horm 2014;94:253-75. [PMID: 24388194 DOI: 10.1016/B978-0-12-800095-3.00010-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
603 Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, Kim HS, Kim WC, Kim OJ, Kim TG. The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One. 2012;7:e47158. [PMID: 23077562 DOI: 10.1371/journal.pone.0047158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
604 Latzer P, Schlegel U, Theiss C. Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab. CNS Neurosci Ther 2016;22:440-50. [PMID: 26861512 DOI: 10.1111/cns.12516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
605 Ha D, Choi SR, Kwon Y, Park HH, Shin JY. Pattern of adverse events induced by aflibercept and ranibizumab: A nationwide spontaneous adverse event reporting database, 2007-2016. Medicine (Baltimore) 2019;98:e16785. [PMID: 31415382 DOI: 10.1097/MD.0000000000016785] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
606 Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook. Cancer Treat Rev 2020;86:102017. [PMID: 32335505 DOI: 10.1016/j.ctrv.2020.102017] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 49.0] [Reference Citation Analysis]
607 Silverstein DC, Montealegre C, Shofer FS, Otto CM. The association between vascular endothelial growth factor levels and clinically evident peripheral edema in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 2009;19:459-66. [PMID: 19821887 DOI: 10.1111/j.1476-4431.2009.00457.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
608 Langsenlehner T, Renner W, Gerger A, Hofmann G, Thurner E, Kapp KS, Langsenlehner U. Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlenther Onkol 2011;187:784-91. [DOI: 10.1007/s00066-011-1106-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
609 Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol. 2004;167:223-229. [PMID: 15504909 DOI: 10.1083/jcb.200408130] [Cited by in Crossref: 332] [Cited by in F6Publishing: 307] [Article Influence: 18.4] [Reference Citation Analysis]
610 Devaux Y, Azuaje F, Vausort M, Yvorra C, Wagner DR. Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics 2010;10:329-37. [PMID: 20414696 DOI: 10.1007/s10142-010-0169-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
611 Ding ZY, Zou XL, Wei YQ. Cancer microenvironment and cancer vaccine. Cancer Microenviron 2012;5:333-44. [PMID: 22562695 DOI: 10.1007/s12307-012-0107-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
612 Simons M. Angiogenesis: where do we stand now? Circulation 2005;111:1556-66. [PMID: 15795364 DOI: 10.1161/01.CIR.0000159345.00591.8F] [Cited by in Crossref: 295] [Cited by in F6Publishing: 129] [Article Influence: 17.4] [Reference Citation Analysis]
613 Ferrara N. The Role of the VEGF Signaling Pathway in Tumor Angiogenesis. In: Marmé D, editor. Tumor Angiogenesis. Cham: Springer International Publishing; 2019. pp. 211-26. [DOI: 10.1007/978-3-319-33673-2_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
614 Broséus J, Mourah S, Ramstein G, Bernard S, Mounier N, Cuccuini W, Gaulard P, Gisselbrecht C, Brière J, Houlgatte R, Thieblemont C. VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers. Oncotarget 2017;8:90808-24. [PMID: 29207605 DOI: 10.18632/oncotarget.19385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
615 Wu XD, Guo T, Liu L, Wang C, Zhang K, Liu HQ, Wang F, Bai WD, Zhang MY. MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells. Oncotarget 2017;8:58072-85. [PMID: 28938538 DOI: 10.18632/oncotarget.19489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
616 Sarnelli G, Gigli S, Capoccia E, Iuvone T, Cirillo C, Seguella L, Nobile N, D'Alessandro A, Pesce M, Steardo L, Cuomo R, Esposito G. Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway. Phytother Res 2016;30:963-70. [PMID: 26929026 DOI: 10.1002/ptr.5601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
617 Langenberg MH, Witteveen PO, Lankheet NA, Roodhart JM, Rosing H, van den Heuvel IJ, Beijnen JH, Voest EE. Phase 1 study of combination treatment with PTK 787/ZK 222584 and cetuximab for patients with advanced solid tumors: safety, pharmacokinetics, pharmacodynamics analysis. Neoplasia 2010;12:206-13. [PMID: 20126478 DOI: 10.1593/neo.91864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
618 Hollanders K, Van Bergen T, Van de Velde S, Sijnave D, Vandewalle E, Moons L, Stalmans I. Bevacizumab Revisited: Its Use in Different Mouse Models of Ocular Pathologies. Current Eye Research 2014;40:611-21. [DOI: 10.3109/02713683.2014.943910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
619 Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, Langer CJ, DeVore RF, Gaudreault J, Damico LA, Holmgren E, Kabbinavar F. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184-2191. [PMID: 15169807 DOI: 10.1200/jco.2004.11.022] [Cited by in Crossref: 1448] [Cited by in F6Publishing: 437] [Article Influence: 80.4] [Reference Citation Analysis]
620 Heinke J, Patterson C, Moser M. Life is a pattern: vascular assembly within the embryo. Front Biosci (Elite Ed) 2012;4:2269-88. [PMID: 22202036 DOI: 10.2741/541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
621 Kuznetsov MB, Kolobov AV. Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism - Analysis by mathematical modeling. J Theor Biol 2018;451:86-100. [PMID: 29705492 DOI: 10.1016/j.jtbi.2018.04.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
622 Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK. Molecular target based combinational therapeutic approaches in thyroid cancer. J Transl Med 2012;10:81. [PMID: 22548798 DOI: 10.1186/1479-5876-10-81] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
623 Abu-Zeid EH, Khalifa BA, Elewa YHA, Arisha AH, Ismail TA, Hendam BM, Abdel-Hamid SE. Bee venom Apis mellifera lamarckii rescues blood brain barrier damage and neurobehavioral changes induced by methyl mercury via regulating tight junction proteins expression in rat cerebellum. Food Chem Toxicol 2021;154:112309. [PMID: 34062221 DOI: 10.1016/j.fct.2021.112309] [Reference Citation Analysis]
624 Weddell JC, Imoukhuede PI. Quantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modeling. PLoS One 2014;9:e97271. [PMID: 24827582 DOI: 10.1371/journal.pone.0097271] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
625 Escalón MP, Lossos IS. Pharmacotherapy of large B-cell lymphoma. Expert Opin Pharmacother 2008;9:2247-58. [PMID: 18710350 DOI: 10.1517/14656566.9.13.2247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
626 Gramley F, Lorenzen J, Jedamzik B, Gatter K, Koellensperger E, Munzel T, Pezzella F. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc Pathol 2010;19:102-11. [PMID: 19211267 DOI: 10.1016/j.carpath.2008.11.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
627 Bhaskar A, Gupta R, Vishnubhatla S, Kumar L, Sharma A, Sharma MC, Das P, Thakur SC. Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma. Leukemia & Lymphoma 2013;54:1473-8. [DOI: 10.3109/10428194.2012.745523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
628 Moore NA, Bracha P, Hussain RM, Morral N, Ciulla TA. Gene therapy for age-related macular degeneration. Expert Opin Biol Ther 2017;17:1235-44. [PMID: 28726562 DOI: 10.1080/14712598.2017.1356817] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
629 Rhee SH, Ma EL, Lee Y, Taché Y, Pothoulakis C, Im E. Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway. J Biol Chem 2015;290:26194-203. [PMID: 26350463 DOI: 10.1074/jbc.M115.678979] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
630 Zhang Y, Liu J, Lin J, Zhou L, Song Y, Wei B, Luo X, Chen Z, Chen Y, Xiong J, Xu X, Ding L, Ye Q. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer. Oncotarget 2016;7:9859-75. [PMID: 26848522 DOI: 10.18632/oncotarget.7126] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
631 Tao J, Zhang L, Zhang X, Chen Y, Chen Q, Shen M, Liu H, Deng S. Effect of Exogenous Melatonin on the Development of Mice Ovarian Follicles and Follicular Angiogenesis. Int J Mol Sci 2021;22:11262. [PMID: 34681919 DOI: 10.3390/ijms222011262] [Reference Citation Analysis]
632 Brennan LJ, Morton JS, Davidge ST. Vascular dysfunction in preeclampsia. Microcirculation 2014;21:4-14. [PMID: 23890192 DOI: 10.1111/micc.12079] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
633 Matsuda T, Kuwana M, Aomizu T, Yamagishi M, Ohtake H, Watanabe G. Surface design for in situ capture of endothelial progenitor cells: VEGF-bound surface architecture and behaviors of cultured mononuclear cells. J Biomed Mater Res 2013;101B:50-60. [DOI: 10.1002/jbm.b.32812] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
634 Moustakas A, Kreisl TN. New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. Onco Targets Ther 2010;3:27-38. [PMID: 20616955 DOI: 10.2147/ott.s5307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
635 Ochman S, Frey S, Raschke MJ, Deventer JN, Meffert RH. Local application of VEGF compensates callus deficiency after acute soft tissue trauma-results using a limb-shortening distraction procedure in rabbit tibia: VEGF COMPENSATES CALLUS DEFICIENCY AFTER ACUTE TRAUMA. J Orthop Res 2011;29:1093-8. [DOI: 10.1002/jor.21340] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
636 Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sciences 2006;79:2370-81. [DOI: 10.1016/j.lfs.2006.08.005] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 7.6] [Reference Citation Analysis]
637 Goto Y. Experimental animal models of diabetes mellitus. Nihon Rinsho. 1991;49 Suppl:789-795. [PMID: 1851902 DOI: 10.1016/j.ygyno.2006.10.062] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 1.5] [Reference Citation Analysis]
638 Jain VK, Hawkes EA, Cunningham D. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer. Clin Colorectal Cancer 2011;10:245-57. [PMID: 21729675 DOI: 10.1016/j.clcc.2011.04.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
639 Schuster C, Akslen LA, Straume O. Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study. PLoS One 2016;11:e0155242. [PMID: 27166673 DOI: 10.1371/journal.pone.0155242] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
640 Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. PLoS One 2012;7:e52279. [PMID: 23300633 DOI: 10.1371/journal.pone.0052279] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
641 Peat FJ, Colbath AC, Bentsen LM, Goodrich LR, King MR. In Vitro Effects of High-Intensity Laser Photobiomodulation on Equine Bone Marrow-Derived Mesenchymal Stem Cell Viability and Cytokine Expression. Photomed Laser Surg 2018;36:83-91. [PMID: 29131717 DOI: 10.1089/pho.2017.4344] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
642 Yar M, Shahzadi L, Mehmood A, Raheem MI, Román S, Chaudhry AA, ur Rehman I, Ian Douglas C, Macneil S. Deoxy-sugar releasing biodegradable hydrogels promote angiogenesis and stimulate wound healing. Materials Today Communications 2017;13:295-305. [DOI: 10.1016/j.mtcomm.2017.10.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
643 Shirai K, Chakravarti A. Towards personalized therapy for patients with glioblastoma. Expert Rev Anticancer Ther 2011;11:1935-44. [PMID: 22117160 DOI: 10.1586/era.11.103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
644 Marks ECA, Wilkinson TM, Frampton CM, Skelton L, Pilbrow AP, Yandle TG, Pemberton CJ, Doughty RN, Whalley GA, Ellis CJ, Troughton RW, Owen MC, Pattinson NR, Cameron VA, Richards AM, Gieseg SP, Palmer BR. Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes. BMC Cardiovasc Disord 2018;18:169. [PMID: 30111293 DOI: 10.1186/s12872-018-0894-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
645 Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, Fuh G, Gerber HP, Ferrara N. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 2007;25:911-20. [PMID: 17664940 DOI: 10.1038/nbt1323] [Cited by in Crossref: 632] [Cited by in F6Publishing: 580] [Article Influence: 42.1] [Reference Citation Analysis]
646 Yang Q, Liu R, Yu Q, Bi Y, Liu G. Metabolic regulation of inflammasomes in inflammation. Immunology 2019;157:95-109. [PMID: 30851192 DOI: 10.1111/imm.13056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
647 Jenny B, Harrison JA, Baetens D, Tille JC, Burkhardt K, Mottaz H, Kiss JZ, Dietrich PY, De Tribolet N, Pizzolato GP, Pepper MS. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. J Pathol 2006;209:34-43. [PMID: 16523449 DOI: 10.1002/path.1943] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
648 Roux BM, Cheng MH, Brey EM. Engineering clinically relevant volumes of vascularized bone. J Cell Mol Med 2015;19:903-14. [PMID: 25877690 DOI: 10.1111/jcmm.12569] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
649 Amundson LA, Hernandez LL, Crenshaw TD. Gene expression of matrix metalloproteinase 9 (MMP9), matrix metalloproteinase 13 (MMP13), vascular endothelial growth factor (VEGF) and fibroblast growth factor 23 (FGF23) in femur and vertebra tissues of the hypovitaminosis D kyphotic pig model. Br J Nutr 2018;120:404-14. [PMID: 29991364 DOI: 10.1017/S0007114518001605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
650 Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH. Cell-Demanded Liberation of VEGF 121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth. Circulation Research 2004;94:1124-32. [DOI: 10.1161/01.res.0000126411.29641.08] [Cited by in Crossref: 289] [Cited by in F6Publishing: 88] [Article Influence: 16.1] [Reference Citation Analysis]
651 Hiller J, Stratmann B, Timm J, Costea TC, Tschoepe D. Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma. Diabet Med 2022;:e14787. [PMID: 35007358 DOI: 10.1111/dme.14787] [Reference Citation Analysis]
652 Chen X, Lv Y, Zhao D, Zhang L, Zheng F, Yang J, Li X, Wang L, Guo L, Pan Y, Yan Y, Chen S, Wang J, Tang J, Wan Y. Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis. Mol Cell Biochem 2016;413:9-23. [DOI: 10.1007/s11010-015-2622-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
653 Hu X, Neoh KG, Zhang J, Kang E, Wang W. Immobilization strategy for optimizing VEGF's concurrent bioactivity towards endothelial cells and osteoblasts on implant surfaces. Biomaterials 2012;33:8082-93. [DOI: 10.1016/j.biomaterials.2012.07.057] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
654 Jones WS, Annex BH. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Current Opinion in Cardiology 2007;22:458-63. [DOI: 10.1097/hco.0b013e328236741b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
655 Yu X, Li W, Deng Q, You S, Liu H, Peng S, Liu X, Lu J, Luo X, Yang L, Tang M, Weng X, Yi W, Liu W, Wu S, Ding Z, Feng T, Zhou J, Fan J, Bode AM, Dong Z, Liu J, Cao Y. Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production. Mol Carcinog 2017;56:1414-26. [PMID: 27996164 DOI: 10.1002/mc.22602] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
656 Chapal M, Néel M, Le Borgne F, Meffray E, Carceles O, Hourmant M, Giral M, Foucher Y, Moreau A, Fakhouri F. Increased Soluble Flt-1 Correlates With Delayed Graft Function and Early Loss of Peritubular Capillaries in the Kidney Graft. Transplantation 2013;96:739-44. [DOI: 10.1097/tp.0b013e31829f4772] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
657 Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 2010;10:505-14. [PMID: 20574450 DOI: 10.1038/nrc2868] [Cited by in Crossref: 465] [Cited by in F6Publishing: 444] [Article Influence: 38.8] [Reference Citation Analysis]
658 Aggarwal S, Parveen F, Faridi RM, Phadke S, Borkar M, Agrawal S. Vascular endothelial growth factor gene polymorphisms in North Indian patients with recurrent miscarriages. Reproductive BioMedicine Online 2011;22:59-64. [DOI: 10.1016/j.rbmo.2010.08.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
659 Armstrong AJ, Carducci MA. New drugs in prostate cancer. Curr Opin Urol 2006;16:138-45. [PMID: 16679849 DOI: 10.1097/01.mou.0000193390.69845.bb] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
660 Foehring D, Brand-Saberi B, Theiss C. VEGF-induced growth cone enhancement is diminished by inhibiting tyrosine-residue 1214 of VEGFR-2. Cells Tissues Organs 2012;196:195-205. [PMID: 22433970 DOI: 10.1159/000334600] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
661 Bosquiazzo VL, Varayoud J, Muñoz-de-Toro M, Luque EH, Ramos JG. Effects of neonatal exposure to bisphenol A on steroid regulation of vascular endothelial growth factor expression and endothelial cell proliferation in the adult rat uterus. Biol Reprod 2010;82:86-95. [PMID: 19696011 DOI: 10.1095/biolreprod.109.078543] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
662 Bluff JE, Menakuru SR, Cross SS, Higham SE, Balasubramanian SP, Brown NJ, Reed MW, Staton CA. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br J Cancer 2009;101:666-72. [PMID: 19623180 DOI: 10.1038/sj.bjc.6605196] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
663 Zhao N, Coyne J, Xu M, Zhang X, Suzuki A, Shi P, Lai J, Fong GH, Xiong N, Wang Y. Assembly of Bifunctional Aptamer-Fibrinogen Macromer for VEGF Delivery and Skin Wound Healing. Chem Mater 2019;31:1006-15. [PMID: 31558852 DOI: 10.1021/acs.chemmater.8b04486] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
664 Pascual-Castroviejo I, Pascual-Pascual SI, López-Gutiérrez JC, Velazquez-Fragua R, Viaño J. Facial hemangioma and hemispheric migration disorder: presentation of 5 patients. AJNR Am J Neuroradiol 2007;28:1609-12. [PMID: 17846222 DOI: 10.3174/ajnr.A0583] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
665 de Paulis A, Prevete N, Fiorentino I, Rossi FW, Staibano S, Montuori N, Ragno P, Longobardi A, Liccardo B, Genovese A, Ribatti D, Walls AF, Marone G. Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol 2006;177:7322-31. [PMID: 17082651 DOI: 10.4049/jimmunol.177.10.7322] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
666 Chen Y, Zhao M, Zheng T, Adlat S, Jin H, Wang C, Li D, Zaw Myint MZ, Yao Y, Xu L, San M, Wen H, Zhang Y, Lu X, Yang L, Zhang L, Feng X, Zheng Y. Repression of adipose vascular endothelial growth factor reduces obesity through adipose browning. Am J Physiol Endocrinol Metab 2019;316:E145-55. [PMID: 30398903 DOI: 10.1152/ajpendo.00196.2018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
667 Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012;320:130-7. [PMID: 22425960 DOI: 10.1016/j.canlet.2012.03.008] [Cited by in Crossref: 225] [Cited by in F6Publishing: 221] [Article Influence: 22.5] [Reference Citation Analysis]
668 Puszko AK, Sosnowski P, Rignault-Bricard R, Hermine O, Hopfgartner G, Pułka-Ziach K, Lepelletier Y, Misicka A. Urea-Peptide Hybrids as VEGF-A165/NRP-1 Complex Inhibitors with Improved Receptor Affinity and Biological Properties. Int J Mol Sci 2020;22:E72. [PMID: 33374715 DOI: 10.3390/ijms22010072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
669 Mottaghitalab F, Hosseinkhani H, Shokrgozar MA, Mao C, Yang M, Farokhi M. Silk as a potential candidate for bone tissue engineering. Journal of Controlled Release 2015;215:112-28. [DOI: 10.1016/j.jconrel.2015.07.031] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 12.0] [Reference Citation Analysis]
670 Shi L, Wu T, Wang Z, Xue J, Xu Y. Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2. Bioorganic & Medicinal Chemistry 2014;22:4735-44. [DOI: 10.1016/j.bmc.2014.07.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
671 Zhao H, Zhang Y, Liu B, Li L, Zhang L, Bao M, Guo H, Xu H, Feng H, Xiao L, Yi W, Yi J, Chen P, Lu C, Lu A. Identification of Characteristic Autoantibodies Associated With Deficiency Pattern in Traditional Chinese Medicine of Rheumatoid Arthritis Using Protein Chips. Front Pharmacol 2019;10:755. [PMID: 31354478 DOI: 10.3389/fphar.2019.00755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
672 Nishimura R, Okuda K. Multiple roles of hypoxia in ovarian function: roles of hypoxia-inducible factor-related and -unrelated signals during the luteal phase. Reprod Fertil Dev 2016;28:1479. [DOI: 10.1071/rd15010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
673 Rahim M, Hobbs H, van der Merwe W, Posthumus M, Collins M, September AV. Investigation of angiogenesis genes with anterior cruciate ligament rupture risk in a South African population. J Sports Sci 2018;36:551-7. [PMID: 28502223 DOI: 10.1080/02640414.2017.1322710] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
674 Jia H, Bagherzadeh A, Bicknell R, Duchen MR, Liu D, Zachary I. Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells. J Biol Chem. 2004;279:36148-36157. [PMID: 15215251 DOI: 10.1074/jbc.M401538200] [Cited by in Crossref: 61] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
675 Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol. 2004;31:2-11. [PMID: 15179620 DOI: 10.1053/j.seminoncol.2004.03.040] [Cited by in Crossref: 232] [Cited by in F6Publishing: 230] [Article Influence: 12.9] [Reference Citation Analysis]
676 Evans CE, Branco-price C, Johnson RS. HIF-mediated endothelial response during cancer progression. Int J Hematol 2012;95:471-7. [DOI: 10.1007/s12185-012-1072-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
677 Ho VC, Duan LJ, Cronin C, Liang BT, Fong GH. Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice. Circulation 2012;126:741-52. [PMID: 22753193 DOI: 10.1161/CIRCULATIONAHA.112.091603] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
678 Hyman NH. What’s new in colon and rectal surgery. Journal of the American College of Surgeons 2004;199:917-23. [DOI: 10.1016/j.jamcollsurg.2004.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
679 Mudyanadzo TA. Endothelial Progenitor Cells and Cardiovascular Correlates. Cureus 2018;10:e3342. [PMID: 30473975 DOI: 10.7759/cureus.3342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
680 Li W, Yan Q, Ding X, Shen C, Hu M, Zhu Y, Qin D, Lu H, Krueger BJ, Renne R, Gao SJ, Lu C. The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA. PLoS Pathog 2016;12:e1005605. [PMID: 27128969 DOI: 10.1371/journal.ppat.1005605] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
681 Varon C, Basoni C, Reuzeau E, Moreau V, Kramer IJ, Génot E. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA. Exp Cell Res 2006;312:3604-19. [PMID: 16978608 DOI: 10.1016/j.yexcr.2006.08.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
682 Durm G, Hanna N. Targeting multiple angiogenic pathways simultaneously: experience with nintedanib in non-small-cell lung cancer. Future Oncology 2014;10:1167-73. [DOI: 10.2217/fon.14.74] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
683 Patil A, Sable R, Kothari R. Occurrence, biochemical profile of vascular endothelial growth factor (VEGF) isoforms and their functions in endochondral ossification. J Cell Physiol 2012;227:1298-308. [DOI: 10.1002/jcp.22846] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
684 Jay SM, Lee RT. Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair. Circ Res 2013;113:933-43. [PMID: 24030023 DOI: 10.1161/CIRCRESAHA.113.300215] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
685 Najar MA, Arefian M, Sidransky D, Gowda H, Prasad TSK, Modi PK, Chatterjee A. Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma. Front Genet 2022;13:854764. [DOI: 10.3389/fgene.2022.854764] [Reference Citation Analysis]
686 Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE, van Westen D, Londos E, Cenci MA, Hansson O. Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology 2015;85:1834-42. [PMID: 26511451 DOI: 10.1212/WNL.0000000000002151] [Cited by in Crossref: 68] [Cited by in F6Publishing: 43] [Article Influence: 9.7] [Reference Citation Analysis]
687 Shin IS, Lee MY, Jeon WY, Kim JC, Shin HK. Ojeok-san, a traditional Korean herbal medicine attenuates airway inflammation and pulmonary fibrosis induced by repeated ovalbumin challenge. J Ethnopharmacol 2013;149:281-7. [PMID: 23816501 DOI: 10.1016/j.jep.2013.06.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
688 Nakao S, Hata Y. An Overview of Diabetes and Ocular Health. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Elsevier; 2012. pp. 159-76. [DOI: 10.1016/b978-0-12-385083-6.00013-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
689 Wang Y, La M, Pham T, Lovrecz GO, Nie G. High levels of HtrA4 detected in preeclamptic circulation may disrupt endothelial cell function by cleaving the main VEGFA receptor KDR. FASEB J 2019;33:5058-66. [PMID: 30601675 DOI: 10.1096/fj.201802151RR] [Cited by in Crossref: 6] [